搜索此博客

2017年8月2日星期三

2017.8.3 list

2017 China CPHI: E1M35
EOS Med Chem, Medchem is Big
執大象，天下往，往而無害，安平泰
網址: www.eosmedchem.com 
労働時間: Beijing Time 4:00AM~11:00PM
郵箱: info@eosmedchem.com; eosmedchem@gmail.com 
辦公室: 0086-531-69905422-806(直通)
攜帶番號 & WhatsApp & Wechat: +8618653174435
住所: Diaozhen Chemical Industrial Park, Jinan City, China
Skype: willgutian
QQ: 2393923585

Catalog No.Name Cas No.FormulaMolecular WeightSmile
EOS-AX0371Adrenomedullin (1-12), humanC64H100N22O19S1513.68N[C@@H](CC1=CC=C(O)C=C1)C(N[C@@H](CCCNC(N)=N)C(N[C@@H](CCC(N)=O)C(N[C@@H](CO)C(N[C@@H](CCSC)C(N[C@@H](CC(N)=O)C(N[C@@H](CC(N)=O)C(N[C@@H](CC2=CC=CC=C2)C(N[C@@H](CCC(N)=O)C(NCC(N[C@@H](CC(C)C)C(N[C@@H](CCCNC(N)=N)C(O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O
EOS-AX0372Beta-Amyloid (1-11)190436-05-6C56H76N16O221325.3CC(C(=O)NC(CCC(=O)O)C(=O)NC(CC1=CC=CC=C1)C(=O)NC(CCCN=C(N)N)C(=O)NC(CC2=CN=CN2)C(=O)NC(CC(=O)O)C(=O)NC(CO)C(=O)NCC(=O)NC(CC3=CC=C(C=C3)O)C(=O)NC(CCC(=O)O)C(=O)O)NC(=O)C(CC(=O)O)N
EOS-AX0373Amyloid β-Protein (1-15)183745-81-5C78H107N25O271826.86CC(C)C(C(=O)NC(CC1=CNC=N1)C(=O)NC(CC2=CNC=N2)C(=O)NC(CCC(=O)N)C(=O)O)NC(=O)C(CCC(=O)O)NC(=O)C(CC3=CC=C(C=C3)O)NC(=O)CNC(=O)C(CO)NC(=O)C(CC(=O)O)NC(=O)C(CC4=CNC=N4)NC(=O)C(CCCNC(=N)N)NC(=O)C(CC5=CC=CC=C5)NC(=O)C(CCC(=O)O)NC(=O)C(C)NC(=O)C(CC(=O)O)N
EOS-AX0374Amyloid Precursor C-Terminal PeptideC86H118N20O27S11896.04
EOS-AX0375Beta-Sheet Breaker Peptide iAβ5182912-74-9C33H43N5O8637.73N[C@@H](CC(C)C)C(N1[C@@H](CCC1)C(N[C@@H](CC2=CC=CC=C2)C(N[C@@H](CC3=CC=CC=C3)C(N[C@@H](CC(O)=O)C(O)=O)=O)=O)=O)=O
EOS-AX0376Angiotensin I (human, mouse, rat)484-42-4C62H89N17O141296.5CCC(C)C(C(=O)NC(CC1=CN=CN1)C(=O)N2CCCC2C(=O)NC(CC3=CC=CC=C3)C(=O)NC(CC4=CN=CN4)C(=O)NC(CC(C)C)C(=O)O)NC(=O)C(CC5=CC=C(C=C5)O)NC(=O)C(C(C)C)NC(=O)C(CCCN=C(N)N)NC(=O)C(CC(=O)O)N
EOS-AX0377Angiotensin 1/2 (1-9)34273-12-6C56H78N16O131183.32CCC(C)C(C(=O)NC(CC1=CN=CN1)C(=O)N2CCCC2C(=O)NC(CC3=CC=CC=C3)C(=O)NC(CC4=CN=CN4)C(=O)O)NC(=O)C(CC5=CC=C(C=C5)O)NC(=O)C(C(C)C)NC(=O)C(CCCN=C(N)N)NC(=O)C(CC(=O)O)N
EOS-AX0378Anti-Inflammatory Peptide 1118850-71-8C45H82N12O14S21079.33CC(C)CC(C(=O)NC(CC(=O)O)C(=O)NC(CO)C(=O)O)NC(=O)C(C(C)C)NC(=O)C(CCCCN)NC(=O)C(CCCCN)NC(=O)C(CCSC)NC(=O)C(CCC(=O)N)NC(=O)C(CCSC)N
EOS-AX0379ANP (1-11), ratC49H84N20O15S1225.38N[C@@H](CO)C(N[C@@H](CC(C)C)C(N[C@@H](CCCNC(N)=N)C(N[C@@H](CCCNC(N)=N)C(N[C@@H](CO)C(N[C@@H](CO)C(N[C@@H](CS)C(N[C@@H](CC1=CC=CC=C1)C(NCC(NCC(N[C@@H](CCCNC(N)=N)C(O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O
EOS-AX0380Myelopeptide-2 (MP-2)C41H57N7O8775.93N[C@@H](CC(C)C)C(N[C@@H](C(C)C)C(N[C@@H](C(C)C)C(N[C@@H](CC1=CC=C(O)C=C1)C(N2[C@@H](CCC2)C(N[C@@H](CC3=CC(C=CC=C4)=C4N3)C(O)=O)=O)=O)=O)=O)=O
EOS-AX0381b-Casomorphin (1-3)72122-59-9C23H27N3O5425.48C1CC(N(C1)C(=O)C(CC2=CC=C(C=C2)O)N)C(=O)NC(CC3=CC=CC=C3)C(=O)O
EOS-AX0382Dynorphin (2-17), amide, porcineC90H147N31O201983.33
EOS-AX0383Endomorphin-1189388-22-5C34H38N6O5610.67C1CC(N(C1)C(=O)C(CC2=CC=C(C=C2)O)N)C(=O)NC(CC3=CNC4=CC=CC=C43)C(=O)NC(CC5=CC=CC=C5)C(=O)N
EOS-AX0384Beta-Lipotropin (1-10), porcine77875-68-4C42H66N10O15951.03N[C@@H](CCC(O)=O)C(N[C@@H](CC(C)C)C(N[C@@H](C)C(NCC(N[C@@H](C)C(N1[C@@H](CCC1)C(N2[C@@H](CCC2)C(N[C@@H](CCC(O)=O)C(N3[C@@H](CCC3)C(N[C@@H](C)C(O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O
EOS-AX0385alpha-Endorphin59004-96-5C77H120N18O26S1745.95CC(C)CC(C(=O)NC(C(C)C)C(=O)NC(C(C)O)C(=O)O)NC(=O)C1CCCN1C(=O)C(C(C)O)NC(=O)C(CCC(=O)N)NC(=O)C(CO)NC(=O)C(CCCCN)NC(=O)C(CCC(=O)O)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C(CCSC)NC(=O)C(CC2=CC=CC=C2)NC(=O)CNC(=O)CNC(=O)C(CC3=CC=C(C=C3)O)N
EOS-AX0386Ac-Endothelin-1 (16-21), humanC41H59N9O10837.96O=C(N[C@@H](CC(C)C)C(N[C@@H](CC(O)=O)C(N[C@@H]([C@H](C)CC)C(N[C@@H]([C@H](C)CC)C(N[C@@H](CC1=CC(C=CC=C2)=C2N1)C(O)=O)=O)=O)=O)=O)[C@H](CC3=CNC=N3)NC(C)=O
EOS-AX0387Adrenorphin, Free Acid88866-92-6C44H68N14O10S985.16CC(C)C(C(=O)O)NC(=O)C(CCCN=C(N)N)NC(=O)C(CCCN=C(N)N)NC(=O)C(CCSC)NC(=O)C(CC1=CC=CC=C1)NC(=O)CNC(=O)CNC(=O)C(CC2=CC=C(C=C2)O)N
EOS-AX0388Platelet Membrane Glycoprotein IIB Peptide (296-306)C47H75N17O201198.2N[C@@H]([C@H](C)O)C(N[C@@H](CC(O)=O)C(N[C@@H](C(C)C)C(N[C@@H](CC(N)=O)C(NCC(N[C@@H](CC(O)=O)C(NCC(N[C@@H](CCCNC(N)=N)C(N[C@@H](CC1=CNC=N1)C(N[C@@H](CC(O)=O)C(N[C@@H](CC(C)C)C(O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O
EOS-AX0389Glucagon (19-29), human64790-15-4C61H89N15O18S1352.51CC(C)CC(C(=O)NC(CCSC)C(=O)NC(CC(=O)N)C(=O)NC(C(C)O)C(=O)O)NC(=O)C(CC1=CNC2=CC=CC=C21)NC(=O)C(CCC(=O)N)NC(=O)C(C(C)C)NC(=O)C(CC3=CC=CC=C3)NC(=O)C(CC(=O)O)NC(=O)C(CCC(=O)N)NC(=O)C(C)N
EOS-AX0390GnRH Associated Peptide (GAP) (1-13), human100111-07-7C65H101N15O251492.58CCC(C)C(C(=O)NC(C(C)C)C(=O)O)NC(=O)C(CCC(=O)O)NC(=O)C(CCC(=O)N)NC(=O)C(CC1=CC=CC=C1)NC(=O)C(CO)NC(=O)C(CC(=O)O)NC(=O)C(C(C)CC)NC(=O)C(CC(C)C)NC(=O)C(CC(=O)N)NC(=O)C(CCC(=O)O)NC(=O)C(C)NC(=O)C(CC(=O)O)N
EOS-AX0391Epidermal Growth Factor Receptor Peptide (985-996)96249-43-3C61H93N13O231376.46CN1CCN(CC1)C2=C(C3=C(C(=C2F)N)C(=O)C(=CN3C4CC4)C(=O)O)F
EOS-AX0392GTP-Binding Protein Fragment, G alphaC66H118N20O23S21623.89
EOS-AX0393Laminin (925-933)110590-60-8C40H62N12O14S967.06CCC(C)C(C(=O)NCC(=O)NC(CO)C(=O)NC(CCCN=C(N)N)C(=O)O)NC(=O)C(CC1=CC=C(C=C1)O)NC(=O)CNC(=O)C2CCCN2C(=O)C(CC(=O)O)NC(=O)C(CS)N
EOS-AX0394LEP (116-130) (mouse)258276-95-8C64H109N19O24S1560.73CC(C)CC(C(=O)NC(CCC(=O)N)C(=O)NC(CCCCN)C(=O)N1CCCC1C(=O)NC(CCC(=O)O)C(=O)NC(CO)C(=O)N)NC(=O)CNC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C(CCC(=O)N)NC(=O)C2CCCN2C(=O)C(CC(C)C)NC(=O)C(CO)NC(=O)C(CS)NC(=O)C(CO)N
EOS-AX0395a-MSH, amideC77H109N21O19S11664.9
EOS-AX0396β-Interleukin I (163-171), human106021-96-9C39H64N12O191004.99CC(C)C(C(=O)NC(CCC(=O)N)C(=O)NCC(=O)NC(CCC(=O)O)C(=O)NC(CCC(=O)O)C(=O)NC(CO)C(=O)NC(CC(=O)N)C(=O)NC(CC(=O)O)C(=O)NC(CCCCN)C(=O)O)N
EOS-AX0397β-Interleukin II (44-56)C68H113N19O191500.74C[C@@H](CC)[C@H](N)C(N[C@H](CC(C)C)C(N[C@H](CC(N)=O)C(NCC(N[C@H]([C@@H](CC)C)C(N[C@H](CC(N)=O)C(N[C@H](CC(N)=O)C(N[C@H](CC1=CC=C(O)C=C1)C(N[C@H](CCCCN)C(N[C@H](CC(N)=O)C(N2CCC[C@H]2C(N[C@H](CCCCN)C(N[C@H](CC(C)C)C(O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O
EOS-AX0398Cadherin Peptide, avian127650-08-2C44H75N17O131050.17CC(C)CC(C(=O)NC(CCCN=C(N)N)C(=O)NC(C)C(=O)NC(CC1=CN=CN1)C(=O)NC(C)C(=O)NC(C(C)C)C(=O)NC(CC(=O)O)C(=O)NC(C(C)C)C(=O)NC(CC(=O)N)C(=O)NCC(=O)N)N
EOS-AX0399Fas C- Terminal Tripeptide189109-90-8C16H29N3O6359.42CC(N[C@@H](CO)C(N[C@@H](CC(C)C)C(N[C@@H](C(C)C)C(O)=O)=O)=O)=O
EOS-AX0400Interleukin II (60-70)C68H104N14O14S11373.7N[C@@H](CC(C)C)C(N[C@H]([C@@H](C)O)C(N[C@H](CC1=CC=CC=C1)C(N[C@H](CCCCN)C(N[C@H](CC2=CC=CC=C2)C(N[C@H](CC3=CC=C(O)C=C3)C(N[C@H](CCSC)C(N4CCC[C@@H]4C(N[C@@H](CCCCN)C(N[C@@H](CCCCN)C(N[C@@H](C)C(O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O
EOS-AX0401Myelin Basic Protein (68-82), guinea pig98474-59-0C71H113N23O281736.81
EOS-AX0402Adrenorphin88377-68-8C44H69N15O9S984.18CC(C)C(C(=O)N)NC(=O)C(CCCN=C(N)N)NC(=O)C(CCCN=C(N)N)NC(=O)C(CCSC)NC(=O)C(CC1=CC=CC=C1)NC(=O)CNC(=O)CNC(=O)C(CC2=CC=C(C=C2)O)N
EOS-AX0403[Ser25] Protein Kinase C (19-31)136795-05-6C67H118N26O171559.82CC(C)CC(C(=O)NC(CCCN=C(N)N)C(=O)NC(CCC(=O)N)C(=O)NC(CCCCN)C(=O)NC(CC(=O)N)C(=O)NC(C(C)C)C(=O)O)NC(=O)C(CO)NC(=O)CNC(=O)C(CCCCN)NC(=O)C(CCCN=C(N)N)NC(=O)C(C)NC(=O)C(CC1=CC=CC=C1)NC(=O)C(CCCN=C(N)N)N
EOS-AX0404Acetyl Angiotensinogen (1-14), porcine66641-26-7C87H125N21O211801.05CCC(C)C(C(=O)NC(CC1=CN=CN1)C(=O)N2CCCC2C(=O)NC(CC3=CC=CC=C3)C(=O)NC(CC4=CN=CN4)C(=O)NC(CC(C)C)C(=O)NC(CC(C)C)C(=O)NC(C(C)C)C(=O)NC(CC5=CC=C(C=C5)O)C(=O)NC(CO)C(=O)O)NC(=O)C(CC6=CC=C(C=C6)O)NC(=O)C(C(C)C)NC(=O)C(CCCNC(=N)N)NC(=O)C(CC(=O)O)NC(=O)C
EOS-AX0405Papain Inhibitor70195-20-9C19H29N7O6451.48C1=CC(=CC=C1CC(C(=O)NC(CCCN=C(N)N)C(=O)O)NC(=O)CNC(=O)CN)O
EOS-AX0406Thrombin Receptor Activator for Peptide 5 (TRAP-5)141685-53-2C30H50N8O7634.77CC(C)CC(C(=O)NC(CC(C)C)C(=O)NC(CCCN=C(N)N)C(=O)O)NC(=O)C(CC1=CC=CC=C1)NC(=O)C(CO)N
EOS-AX0407TRH Precursor PeptideC42H75N19O101006.17C1CC(N(C1)C(=O)C(CC2=CN=CN2)NC(=O)C(CCC(=O)N)NC(=O)C(CCCN=C(N)N)NC(=O)C(CCCCN)N)C(=O)NCC(=O)NC(CCCCN)C(=O)NC(CCCN=C(N)N)C(=O)O
EOS-AX0408Amyloid β-Peptide (10-20) (human)152286-31-2C71H99N17O161446.67CC(C)CC(C(=O)NC(C(C)C)C(=O)NC(CC1=CC=CC=C1)C(=O)NC(CC2=CC=CC=C2)C(=O)O)NC(=O)C(CCCCN)NC(=O)C(CCC(=O)N)NC(=O)C(CC3=CN=CN3)NC(=O)C(CC4=CN=CN4)NC(=O)C(C(C)C)NC(=O)C(CCC(=O)O)NC(=O)C(CC5=CC=C(C=C5)O)N
EOS-AX0409Amyloid Beta-peptide (25-35) (human)131602-53-4C45H81N13O14S1060.27CCC(C)C(C(=O)NC(C(C)CC)C(=O)NCC(=O)NC(CC(C)C)C(=O)NC(CCSC)C(=O)O)NC(=O)C(C)NC(=O)CNC(=O)C(CCCCN)NC(=O)C(CC(=O)N)NC(=O)C(CO)NC(=O)CN
EOS-AX0410Myelin Basic Protein (87-99)118506-26-6C74H114N20O171555.8CCC(C)C(C(=O)NC(C(C)C)C(=O)NC(C(C)O)C(=O)N1CCCC1C(=O)NC(CCCN=C(N)N)C(=O)NC(C(C)O)C(=O)N2CCCC2C(=O)O)NC(=O)C(CC(=O)N)NC(=O)C(CCCCN)NC(=O)C(CC3=CC=CC=C3)NC(=O)C(CC4=CC=CC=C4)NC(=O)C(CC5=CN=CN5)NC(=O)C(C(C)C)N
EOS-AX0411Angiotensin (1-7)51833-78-4C41H62N12O11899CCC(C)C(C(=O)NC(CC1=CN=CN1)C(=O)N2CCCC2C(=O)O)NC(=O)C(CC3=CC=C(C=C3)O)NC(=O)C(C(C)C)NC(=O)C(CCCN=C(N)N)NC(=O)C(CC(=O)O)N
EOS-AX0412Angiotensin II4474-91-3C50H71N13O121046.2CCC(C)C(C(=O)NC(CC1=CN=CN1)C(=O)N2CCCC2C(=O)NC(CC3=CC=CC=C3)C(=O)O)NC(=O)C(CC4=CC=C(C=C4)O)NC(=O)C(C(C)C)NC(=O)C(CCCN=C(N)N)NC(=O)C(CC(=O)O)N.CC(=O)O
EOS-AX0413Angiotensin III (human, mouse)13602-53-4C46H66N12O9931.09CCC(C)C(C(=O)NC(CC1=CN=CN1)C(=O)N2CCCC2C(=O)NC(CC3=CC=CC=C3)C(=O)O)NC(=O)C(CC4=CC=C(C=C4)O)NC(=O)C(C(C)C)NC(=O)C(CCCN=C(N)N)N
EOS-AX0414Gap 26197250-15-0C70H107N19O19S1550.79
EOS-AX0415Gap 27198284-64-9C60H101N15O171304.55CCC(C)C(C(=O)NC(C(C)CC)C(=O)O)NC(=O)C(CC1=CC=CC=C1)NC(=O)C(C(C)CC)NC(=O)C(C(C)O)NC(=O)C(CCCCN)NC(=O)C(CCC(=O)O)NC(=O)C(C(C)O)NC(=O)C2CCCN2C(=O)C(CCCN=C(N)N)NC(=O)C(CO)N
EOS-AX0416Dynamin inhibitory peptide251634-21-6C47H80N18O141121.26CC(C)C(C(=O)N1CCCC1C(=O)NC(CO)C(=O)NC(CCCN=C(N)N)C(=O)N2CCCC2C(=O)NC(CC(=O)N)C(=O)NC(CCCN=C(N)N)C(=O)NC(C)C(=O)N3CCCC3C(=O)O)NC(=O)C(CCC(=O)N)N
EOS-AX0417Angiotensin 1/2 (1-5)58442-64-1C30H48N8O9664.75CCC(C)C(C(=O)O)NC(=O)C(CC1=CC=C(C=C1)O)NC(=O)C(C(C)C)NC(=O)C(CCCN=C(N)N)NC(=O)C(CC(=O)O)N
EOS-AX0418Angiotensin 1/2 (1-6)47896-63-9C36H55N11O10801.89CC1C(C(=O)NC(C(=O)N2CCCC2C(=O)N(CC(=O)N(C(C(=O)O1)C(C)C)C)C)C(C)C)NC(=O)C3=C4C(=C(C=C3)C)OC5=C(C(=O)C(=C(C5=N4)C(=O)NC6C(OC(=O)C(N(C(=O)CN(C(=O)C7CCCN7C(=O)C(NC6=O)C(C)C)C)C)C(C)C)C)N)C
EOS-AX0419Angiotensin 1/2 (5-7)C17H27N5O4365.43N[C@@H]([C@H](C)CC)C(N[C@@H](CC1=CNC=N1)C(N2CCC[C@@H]2C(O)=O)=O)=O
EOS-AX0420Angiotensin 1/2 (2-7)C37H57N11O8783.92N[C@@H](CCCNC(N)=N)C(N[C@@H](C(C)C)C(N[C@@H](CC1=CC=C(O)C=C1)C(N[C@@H]([C@H](C)CC)C(N[C@@H](CC2=CNC=N2)C(N3CCC[C@@H]3C(O)=O)=O)=O)=O)=O)=O
EOS-AX0421alpha-1 antitrypsin fragmentC79H130N22O261804.01NC(CC(C)C)C(NC(CCC(N)=O)C(NC(CC1=CNC=N1)C(NC(CC(C)C)C(NC(CCC(O)=O)C(NC(CC(N)=O)C(NC(CCC(O)=O)C(NC(CC(C)C)C(NC(C(O)C)C(NC(CC2=CNC=N2)C(NC(CC(O)=O)C(NC(C(C)CC)C(NC(C(C)CC)C(NC(C(C)O)C(NC(C(O)=O)CCCCN)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O
EOS-AX0422alpha-1 antitrypsin fragment 235-243 [Homo sapiens]/[Papio hamadryas]/[Cercopithecus aethiops]C51H85N11O12S1076.35N[C@H](C(N[C@@H](CO)C(N[C@@H](CO)C(N[C@@H](CC1=CNC2=C1C=CC=C2)C(N[C@@H](C(C)C)C(N[C@@H](CC(C)C)C(N[C@@H](CC(C)C)C(N[C@@H](CCSC)C(N[C@H](C(O)=O)CCCCN)=O)=O)=O)=O)=O)=O)=O)=O)CC(C)C
EOS-AX0423amyloid A protein fragment [Homo sapiens]C36H56N8O11776.88CC(N)C(NCC(NC(C(N1CCC[C@@H]1C(NC(C(NC(CCCCN)C(N[C@@H](CC2=CC=C(O)C=C2)C(O)=O)=O)=O)CCC(O)=O)=O)=O)CC(C)C)=O)=O
EOS-AX0424Angiotensin 1/2 (1-7) amideC41H63N13O10898.02O=C(N)[C@@H]1N(C([C@@H](NC([C@@H](NC([C@@H](NC([C@@H](NC([C@@H](NC(CNC)=O)CCCNC(N)=N)=O)C)=O)CC2=CC=C(O)C=C2)=O)[C@@H](C)CC)=O)CC3=CNC=N3)=O)CCC1
EOS-AX0425Angiotensin 1/2 (1-8) amideC50H72N14O111045.19OC(C[C@H](N)C(N[C@@H](CCCNC(N)=N)C(N[C@@H](C(C)C)C(N[C@@H](CC1=CC=C(O)C=C1)C(N[C@@H]([C@H](CC)C)C(N[C@H](C(N2[C@H](C(N[C@@H](CC3=CC=CC=C3)C(N)=O)=O)CCC2)=O)CC4=CN=CN4)=O)=O)=O)=O)=O)=O
EOS-AX0426Angiotensin 1/2 + A (2 - 8)51833-76-2C49H71N13O101002.17CCC(C)C(C(=O)NC(CC1=CN=CN1)C(=O)N2CCCC2C(=O)NC(CC3=CC=CC=C3)C(=O)O)NC(=O)C(CC4=CC=C(C=C4)O)NC(=O)C(C(C)C)NC(=O)C(CCCN=C(N)N)NC(=O)C(C)N
EOS-AX0427coagulation factor II (thrombin) B chain fragment [Homo sapiens]C90H137N23O24S1957.26
EOS-AX0428Prothrombin (474-477) [Mus musculus]C26H36N6O6528.6OC1=CC=C(C[C@H](N)C(N[C@@H]([C@H](C)CC)C(NC(CC2=CNC=N2)C(N3CCC[C@]3([H])C(O)=O)=O)=O)=O)C=C1
EOS-AX0429Cyclin D1 C43H71N9O11S2954.21
EOS-AX0430Cyclin dependent kinase inhibitor 2A - Tumor Suppressor C105H186N38O22S22396.97
EOS-AX0431Cytochrome c - pigeon (88-104)86579-06-8C84H144N24O251890.19CCC(C)C(C(=O)NC(C)C(=O)NC(CC1=CC=C(C=C1)O)C(=O)NC(CC(C)C)C(=O)NC(CCCCN)C(=O)NC(CCC(=O)N)C(=O)NC(C)C(=O)NC(C(C)O)C(=O)NC(C)C(=O)NC(CCCCN)C(=O)O)NC(=O)C(CC(C)C)NC(=O)C(CC(=O)O)NC(=O)C(C)NC(=O)C(CCCNC(=N)N)NC(=O)C(CCC(=O)O)NC(=O)C(C)NC(=O)C(CCCCN)N
EOS-AX0432Cytochrome c fragment (93-108)C79H133N23O251805.04
EOS-AX0433Cytochrome P450 CYP1B1 (190-198) [Homo sapiens]C50H80N12O131057.24NC(C(NC(CC(C)C)C(NC(CC(O)=O)C(N1C(C(NC(CCCNC(N)=N)C(N2CCCC2C(NC(CC(C)C)C(NC(C(C)O)C(NC(C(C)C)C(O)=O)=O)=O)=O)=O)=O)CCC1)=O)=O)=O)CC3=CC=CC=C3
EOS-AX0434EGF receptor substrate eps15 acetyl - [Mus musculus]/[Homo sapiens] C96H159N23O392259.42
EOS-AX0435egg white lysozyme (19-36) [Gallus gallus]C86H144N28O23S22002.37
EOS-AX0436erbB-2C50H78N10O11995.21O=C(N[C@@H]([C@H](CC)C)C(N[C@@H](CC1=CC=CC=C1)C(NCC(N[C@@H](CO)C(N[C@@H](CC(C)C)C(N[C@H](C)C(N[C@@H](CC2=CC=CC=C2)C(N[C@@H](CC(C)C)C(O)=O)=O)=O)=O)=O)=O)=O)=O)[C@H](CCCCN)N
EOS-AX0437eukaryotic translation elongation factor 1 alpha 1 (EEF1A1) (387-394) [Multiple species]C43H67N9O13918.04NC(CC(C)C)C(NC(CCC(O)=O)C(NC(CC(O)=O)C(NCC(N(CCC1)C1C(NC(CCCCN)C(NC(CC2=CC=CC=C2)C(NC(CC(C)C)C(O)=O)=O)=O)=O)=O)=O)=O)=O
EOS-AX0438eukaryotic translation initiation factor 3C47H84N14O14S1101.32NC(CC(N)=O)C(NC(CC(C)C)C(NC(CCC(N)=O)C(NC(CC(C)C)C(NC(CC(C)C)C(NC(CCSC)C(NC(CC(O)=O)C(NC(CCCNC(N)=N)C(NC(C(C)C)C(O)=O)=O)=O)=O)=O)=O)=O)=O)=O
EOS-AX0439ferritin heavy chain fragment [Multiple species]C49H80N12O151077.23NC(CC1=CC=C(O)C=C1)C(NC(CC(C)C)C(NC(CC(N)=O)C(NC(CCC(O)=O)C(NC(CCC(N)=O)C(NC(C(C)C)C(NC(CCCCN)C(NC(C)C(NC(C(C)CC)C(O)=O)=O)=O)=O)=O)=O)=O)=O)=O
EOS-AX0440IgG light chain variable region [Homo sapiens]/IgM/kappa antibody [Mus musculus]C37H59N7O13809.9C[C@@H](O)[C@H](N)C(NC(CC(O)=O)C(NC(CC1=CC=CC=C1)C(N[C@@H]([C@@H](O)C)C(NC(CC(C)C)C(N[C@H](C(N[C@H]([C@@H](C)CC)C(O)=O)=O)[C@@H](O)C)=O)=O)=O)=O)=O
EOS-AX0441immunoglobulin light chain variable region fragment [Homo sapiens]C40H69N11O10864.04NC(C(NC(C(C)O)C(NC(CC(C)C)C(NC(CCCCN)C(NC(C(C)CC)C(NC(CO)C(NC(CCCNC(N)=N)C(O)=O)=O)=O)=O)=O)=O)=O)CC1=CC=CC=C1
EOS-AX0442immunoglobulin light chain variable region fragment [Homo sapiens]/[Mus musculus]C54H83N13O131122.32NC(CC(C)C)C(NC(CC(C)C)C(NC(C(C)CC)C(NC(CC1=CC=C(O)C=C1)C(NC(CC2=CNC3=C2C=CC=C3)C(NC(C)C(NC(CO)C(NC(C(O)C)C(NC(CCCNC(N)=N)C(O)=O)=O)=O)=O)=O)=O)=O)=O)=O
EOS-AX0443Immunoglobulin M heavy chain (IGHM) fragment [Homo sapiens]C82H132N24O201774.07
EOS-AX0444immunoglobulin single chain variable fragment acetyl C53H88N12O221245.33
EOS-AX0445Influenza A virus fragmentC46H71N9O10S2974.24CC(CC(C(NC(CCCCN)C(NC(CC1=CC=CC=C1)C(NC(C)C(NC(CC2=CC=CC=C2)C(NC(CO)C(NC(CCSC)C(NC(CCSC)C(O)=O)=O)=O)=O)=O)=O)=O)=O)N)C
EOS-AX0446Insulin like growth factor II fragment variant C33H59N11O13817.89
EOS-AX0447Lamin fragmentC47H76N12O121001.18NC(CCCCN)C(NC(C)C(NCC(NC(CCC(N)=O)C(NC(C(C)C)C(NC(C(C)C)C(NC(C(C)O)C(NC(C(C)CC)C(NC(CC1=CNC2=C1C=CC=C2)C(O)=O)=O)=O)=O)=O)=O)=O)=O)=O
EOS-AX0448Large T antigen - rhesus polyomavirus 560-568C52H87N13O151134.33N[C@H](C(N[C@@H](CCC(O)=O)C(N[C@@H](CC1=CC=CC=C1)C(N[C@@H](CC(C)C)C(N[C@@H](CC(C)C)C(N[C@@H](CCC(O)=O)C(N[C@@H](CCCCN)C(N[C@@H](CCCNC(N)=N)C(N[C@@H]([C@@H](C)CC)C(O)=O)=O)=O)=O)=O)=O)=O)=O)=O)CO
EOS-AX0449MAP kinase fragment [Multiple species]C48H77N13O131044.2NC(CCCCN)C(NC(CC1=CC=C(O)C=C1)C(NC(C(CC)C)C(NC(CC2=CN=CN2)C(NC(CO)C(NC(C)C(NC(CC(N)=O)C(NC(C(C)C)C(NC(CC(C)C)C(O)=O)=O)=O)=O)=O)=O)=O)=O)=O
EOS-AX0450matrix protein (3-15) [Zaire ebolavirus]C69H110N16O20S1515.77NC(CCCNC(N)=N)C(NC(C(C)C)C(NC(C(C)CC)C(NC(CC(C)C)C(N(CCC1)C1C(NC(C(C)O)C(NC(C)C(N2CCCC2C(N3CCCC3C(NC(C(NC(CC4=CC=C(O)C=C4)C(NC(CCSC)C(NC(CCC(O)=O)C(O)=O)=O)=O)=O)CCC(O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O
EOS-AX0451MHC class II antigen (45-57) [Homo sapiens]C73H112N18O251641.78
EOS-AX0452ovalbumin (324-338) [Gallus gallus]/[Coturnix coturnix]C66H105N21O231560.67
EOS-AX0453p53 tumor suppressor fragmentC41H67N11O14S41066.3NC(CCCCN)C(NC(CC1=CC=C(O)C=C1)C(NC(CCSC)C(NC(CS)C(NC(CC(N)=O)C(NC(CO)C(NC(CO)C(NC(CS)C(NC(CCSC)C(O)=O)=O)=O)=O)=O)=O)=O)=O)=O
EOS-AX0454parathyroid hormone (7-34) [Homo sapiens]/[Macaca fascicularis]C154H246N48O40S23474.03
EOS-AX0455prostate apoptosis response protein PAR-4 (2-7) [Homo sapiens]C26H41N9O9623.66CC(C(NC(C(O)C)C(NCC(NCC(NC(CC1=CC=C(O)C=C1)C(NC(CCCNC(N)=N)C(O)=O)=O)=O)=O)=O)=O)N
EOS-AX0456Rac GTPase fragmentC46H74N12O141019.15NC(C(C)C)C(NC(CC1=CC=CC=C1)C(NC(CC(O)=O)C(NC(CCC(O)=O)C(NC(C)C(NC(C(NC(CCCNC(N)=N)C(NC(C)C(NC(C(C)C)C(O)=O)=O)=O)=O)C(C)CC)=O)=O)=O)=O)=O
EOS-AX0457Rhodopsin peptideC51H88N14O201217.33CC(C)C(N)C(NC(CO)C(NC(CCCCN)C(NC(C(O)C)C(NC(CCC(O)=O)C(NC(C(O)C)C(NC(CO)C(NC(C(NC(C(C)C)C(NC(C)C(N1C(C(NC(C)C(O)=O)=O)CCC1)=O)=O)=O)CCC(N)=O)=O)=O)=O)=O)=O)=O)=O
EOS-AX0458Ribosomal protein L3 peptide (202-222) amideC114H182N42O25S2573
EOS-AX0459signal transducer and activator of transcription 5 (322-343) acetyl/amide C115H193N27O332481.92
EOS-AX0460signal transducer and activator of transcription 6 fragmentC54H81N13O151152.3OCC(N)C(NC(CC1=CC=C(O)C=C1)C(NC(CC2=CNC3=C2C=CC=C3)C(NC(CO)C(NC(CC(O)=O)C(NC(CCCNC(N)=N)C(NC(CC(C)C)C(NC(C(C)CC)C(NC(C(CC)C)C(O)=O)=O)=O)=O)=O)=O)=O)=O)=O
EOS-AX0461surface antigen (208-215) [Hepatitis B Virus]C46H74N8O10899.13NC(C(C)CC)C(NC(C(NC(CO)C(N1CCCC1C(NC(CC2=CC=CC=C2)C(NC(CC(C)C)C(N3CCCC3C(NC(C(O)=O)CC(C)C)=O)=O)=O)=O)=O)=O)CC(C)C)=O
EOS-AX0462survivin (baculoviral IAP repeat-containing protein 5) (21-28)C54H73N11O111052.22NC(C(C)O)C(NC(CC1=CC=CC=C1)C(NC(CCCCN)C(NC(CC(N)=O)C(NC(CC2=CNC3=C2C=CC=C3)C(N4C(C(NC(CC5=CC=CC=C5)C(NC(CC(C)C)C(O)=O)=O)=O)CCC4)=O)=O)=O)=O)=O
EOS-AX0463transferrin fragmentC75H121N23O28S1824.97NC(C)C(NC(CC(O)=O)C(NC(CCCNC(N)=N)C(NC(CC(O)=O)C(NC(CCC(N)=O)C(NC(CC1=CC=C(O)C=C1)C(NC(CCC(O)=O)C(NC(CC(C)C)C(NC(CC(C)C)C(NC(CS)C(NC(CC(C)C)C(NC(CC(O)=O)C(NC(CC(N)=O)C(NC(C(C)O)C(NC(CCCNC(N)=N)C(O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O
EOS-AX0464tumor protein p53 binding protein fragment [Homo sapiens]/[Mus musculus]C57H87N13O181242.38OC(C=C1)=CC=C1CC(N)C(NC(CC(C)C)C(NC(CC2=CN=CN2)C(NC(C(C)C)C(NC(CCC(O)=O)C(N3CCCC3C(NC(CCC(O)=O)C(NC(CCCCN)C(NC(CCC(O)=O)C(NC(C(C)C)C(O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O
EOS-AX0465type I hair keratin fragment [Homo sapiens]/[Ovis aries]/[Rattus norvegicus]C47H77N13O151064.19NC(CC(C)C)C(NC(CC(N)=O)C(NC(CC(O)=O)C(NC(CCCNC(N)=N)C(NC(CC(C)C)C(NC(C)C(NC(CO)C(NC(CC1=CC=C(O)C=C1)C(NC(CC(C)C)C(O)=O)=O)=O)=O)=O)=O)=O)=O)=O
EOS-AX0466type II collagen fragmentC65H102N18O211471.61NCC(NC(CCC(O)=O)C(N1CCCC1C(NCC(NC(C(C)CC)C(NC(C)C(NCC(NC(CC2=CC=CC=C2)C(NC(CCCCN)C(NCC(NC(CCC(O)=O)C(NC(CCC(N)=O)C(NCC(N3C(C(NC(CCCCN)C(O)=O)=O)CCC3)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O
EOS-AX0467ubiquitin specific protease 3 fragmentC38H68N10O15S937.07NC(CO)C(NC(C(O)C)C(NC(C(C)O)C(NC(C)C(NC(C(C)CC)C(NC(CS)C(NC(C)C(NC(C(O)C)C(NCC(NC(CC(C)C)C(O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O
EOS-AX0468vitamin D binding protein precrusor (208-218) [Homo sapiens]/[Oryctolagus cuniculus]C54H95N17O171254.44NC(CC1=CN=CN1)C(NC(CC(C)C)C(NC(CO)C(NC(CC(C)C)C(NC(CC(C)C)C(NC(C(C)O)C(NC(C(NC(CC(C)C)C(NC(CO)C(NC(CC(N)=O)C(NC(CCCNC(N)=N)C(O)=O)=O)=O)=O)=O)C(O)C)=O)=O)=O)=O)=O)=O
EOS-AX0469vitamin D binding protein precursor (353-363) [Homo sapiens]C61H99N17O161326.54NC(CCCNC(N)=N)C(NC(C(C)O)C(NC(CC1=CN=CN1)C(NC(CC(C)C)C(N(CCC2)C2C(NC(CCC(O)=O)C(NC(C(C)C)C(NC(CC3=CC=CC=C3)C(NC(CC(C)C)C(NC(CO)C(NC(CCCCN)C(O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O
EOS-AX0470Corticostatin, rabbit C163H259N63O44S63997.7
EOS-AX0471Pro-Adrenomedullin (153-185), humanC143H224N42O433219.6
EOS-AX0472Amyloid β-peptide (10-35), amideC133H205N35O36S12902.4
EOS-AX0473Atrial Natriuretic Factor (1-29), chicken 118691-45-5C124H211N47O40S53160.62
EOS-AX0474Big Endothelin-1 (1-38), human 121014-53-7C189H282N48O56S54282.87
EOS-AX0475BNP (1-32), human114471-18-0C143H244N50O42S43464.04
EOS-AX0476Vasonatrin Peptide (1-27) C124H198N36O36S32865.31
EOS-AX0477Cdk2/Cyclin Inhibitory Peptide IC111H196N48O232571.05
EOS-AX0478Corticotropin Releasing Factor, bovine 92307-52-3C206H340N60O63S14697.33
EOS-AX0479Endostatin (84-114)-NH2 (JKC367)C161H236N48O433531.9
EOS-AX0480Endothelin-2, human 123562-20-9C115H160N26O32S42546.92
EOS-AX0481Endothelin-1 (1-15), amide, humanC70H109N17O23S51717.04
EOS-AX0482Nitric Oxide Synthase (599-613) Blocking Peptide, Bovine Endothelial CellC85H127N25O27S1963.13O=C(NC(CC1=CC=C(O)C=C1)C(NC(CC(N)=O)C(NC(CO)C(NC(CO)C(N2CCCC2C(NC(CCCNC(N)=N)C(N3CCCC3C(NC(CCC(O)=O)C(NC(CCC(N)=O)C(NC(CC4=CN=CN4)C(NC(CCCCN)C(NC(CO)C(NC(CC5=CC=C(O)C=C5)C(NC(CCCCN)C(NC(CS)C(O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)C6CCCN6C(C)=O
EOS-AX0483Diazepam-Binding Inhibitor Fragment, human 104360-70-5C91H148N26O32S2150.37
EOS-AX0484Parathyroid Hormone (1-34), bovine12583-68-5C183H288N54O50S24108.71
EOS-AX0485Peptide YY(3-36), PYY, human123583-37-9C180H279N53O544049.6
EOS-AX0486EGF-R (661-681) T669 Peptide C101H177N31O312321.68
EOS-AX0487PKA inhibitor fragment (6-22) amide121932-06-7C80H130N28O241868.08
EOS-AX0488S6 Kinase Substrate Peptide 32C149H270N56O493630.1
EOS-AX0489Secretin (human) 108153-74-8C130H220N44O403039.44
EOS-AX0490Papilostatin-2 C86H132N30O28S22098.34
EOS-AX0491Melanocyte stimulating hormone release inhibiting factor2002-44-0C13H24N4O3284.36CC(C)CC(C(=O)NCC(=O)N)NC(=O)C1CCCN1
EOS-AX0492Amyloid β-peptide (42-1) (human) 317366-82-8C203H311N55O60S4514.08
EOS-AX0493Amyloid Beta-Peptide (12-28) (human)107015-83-8C89H135N25O251955.2
EOS-AX0494Amyloid Beta-Peptide (1-40) (human)131438-79-4C194H295N53O58S4329.86
EOS-AX0495Amyloid β-peptide (1-40) (rat) 144409-98-3C190H291N51O57S4233.76
EOS-AX0496Amyloid β-Peptide (1-42) (human) 107761-42-2C203H311N55O60S4514.08
EOS-AX0497Amyloid β-peptide (1-42) (rat) 166090-74-0C199H307N53O59S4417.99
EOS-AX0498Amyloid β-Peptide (1-43) (human) 134500-80-4C207H318N56O62S4615.19
EOS-AX0499Parathyroid hormone (1-34) (human)52232-67-4C181H291N55O51S24117.75
EOS-AX0500PKC (19-36) 113731-96-7C93H159N35O242151.48
EOS-AX0501COG 133514200-66-9C97H181N37O192169.73
EOS-AX0502β-Pompilidotoxin216064-36-7C71H124N22O171557.9CCC(C)C(C(=O)NC(CCCCN)C(=O)NC(C(C)CC)C(=O)NCC(=O)NC(CC(C)C)C(=O)NC(CC1=CC=CC=C1)C(=O)NC(CC(=O)O)C(=O)NC(CCC(=O)N)C(=O)NC(CC(C)C)C(=O)NC(CO)C(=O)NC(CCCN=C(N)N)C(=O)NC(CC(C)C)C(=O)N)NC(=O)C(CCCN=C(N)N)N
EOS-AX0503Epidermal growth factor receptor (994-1002) acetyl/amideC51H76N14O15S1157.3OC(CC(NC(C)=O)C(NC(CO)C(NC(CC(N)=O)C(NC(CC1=CC=CC=C1)C(NC(CC2=CC=C(O)C=C2)C(NC(CCCNC(N)=N)C(NC(C)C(NC(CC(C)C)C(NC(CCSC)C(N)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O
EOS-AX0504Agouti-related Protein (AGRP) (25-82), humanC279H468N80O90S16415.39
EOS-AX0505Growth Hormone (1-43), humanC240H358N62O67S15216.2
EOS-AX0506Fusion glycoprotein (92-106) [Human respiratory syncytial virus]C73H124N22O25S1741.96CC(CCC(C(NC(CC(C)C)C(NC(CCC(N)=O)C(NC(CC(C)C)C(NC(C(NC(CCSC)C(NC(CCC(O)=O)C(NC(CO)C(NC(C(O)C)C(N1CCCC1C(N2CCCC2C(NC(C(C)O)C(NC(CC(N)=O)C(NC(CC(N)=O)C(NC(C(O)=O)CCCNC(N)=N)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)CC(C)C)=O)=O)=O)=O)O)=O
EOS-AX0507G protein coupled receptor [Homo sapiens] C110H168N38O452742.74
EOS-AX0508Glycoprotein B (485-492)C41H67N11O13922.04NC(CO)C(NC(CO)C(NC(C(CC)C)C(NC(CCC(O)=O)C(NC(CC1=CC=CC=C1)C(NC(C)C(NC(CCCNC(N)=N)C(NC(CC(C)C)C(O)=O)=O)=O)=O)=O)=O)=O)=O
EOS-AX0509GTP binding protein 1 fragment [Multiple species]C46H77N9O12948.16NC(CCCCN)C(NC(C(C)C)C(NC(C(C)CC)C(NC(C(C)O)C(NC(CC1=CC=CC=C1)C(NC(C(C)CC)C(NC(CC(O)=O)C(NC(CC(C)C)C(O)=O)=O)=O)=O)=O)=O)=O)=O
EOS-AX0510HBcAg [Hepatitis B virus] (18-27)C58H78N10O151155.3N[C@H](C(N[C@H](C(N1[C@@H](CCC1)C(N[C@@H](CO)C(N[C@H](C(N[C@@H](CC2=CC=CC=C2)C(N[C@@H](CC3=CC=CC=C3)C(N4[C@@H](CCC4)C(N[C@H](C(N[C@H](C(O)=O)C(C)C)=O)CO)=O)=O)=O)=O)CC(O)=O)=O)=O)=O)CC(C)C)=O)CC5=CC=CC=C5
EOS-AX0511hemagglutinin (332-340) [Influenza A virus]C42H75N13O13970.12NC(C(C)O)C(NCC(NC(CC(C)C)C(NC(CCCNC(N)=N)C(NC(CC(N)=O)C(NC(C(C)CC)C(N1C(C(NC(CO)C(NC(C(C)CC)C(O)=O)=O)=O)CCC1)=O)=O)=O)=O)=O)=O
EOS-AX0512hemagglutinin precursor (114-122) amide [Influenza A virus]C53H68N10O161101.16NC(CC1=CC=C(O)C=C1)C(N2CCCC2C(NC(CC3=CC=C(O)C=C3)C(NC(CC(O)=O)C(NC(C(C)C)C(N4CCCC4C(NC(CC(O)=O)C(NC(C(NC(C)C(N)=O)=O)CC5=CC=C(O)C=C5)=O)=O)=O)=O)=O)=O)=O
EOS-AX0513heparin cofactor II precursor (SERPIND1) fragment [Homo sapiens]C95H137N23O221953.25
EOS-AX0514heparin cofactor II precursor fragment [Homo sapiens]C65H99N17O181406.58
EOS-AX0515Hepatitis C virus C48H88N10O13S1045.34
EOS-AX0516Histone-H2A-(107-122)-Ac-OHC81H140N20O231762.1CC(NCC(NC(C(C)C)C(NC(CC(C)C)C(N1C(C(NC(CC(N)=O)C(NC(C(CC)C)C(NC(CCC(N)=O)C(NC(C)C(NC(C(NC(CC(C)C)C(NC(CC(C)C)C(N2C(C(NC(CCCCN)C(NC(CCCCN)C(NC(C(C)O)C(NC(C(O)=O)CCC(O)=O)=O)=O)=O)=O)CCC2)=O)=O)=O)C(C)C)=O)=O)=O)=O)=O)CCC1)=O)=O)=O)=O
EOS-AX0517Luteinizing hormone releasing hormone human acetate salt (LHRH)33515-09-2C55H75N17O131182.29CC(C)CC(C(=O)NC(CCCN=C(N)N)C(=O)N1CCCC1C(=O)NCC(=O)N)NC(=O)CNC(=O)C(CC2=CC=C(C=C2)O)NC(=O)C(CO)NC(=O)C(CC3=CNC4=CC=CC=C43)NC(=O)C(CC5=CN=CN5)NC(=O)C6CCC(=O)N6
EOS-AX0518Difopein396834-58-5C273H424N76O89S66387.17
EOS-AX051910058-F4403811-55-2C12H11NOS2249.35CCC1=CC=C(C=C1)C=C2C(=O)NC(=S)S2
EOS-AX0520AG-18118409-57-7C10H6N2O2186.17C1=CC(=C(C=C1C=C(C#N)C#N)O)O
EOS-AX0521AMG-517659730-32-2C20H13F3N4O2S430.4CC(=O)NC1=NC2=C(C=CC=C2S1)OC3=NC=NC(=C3)C4=CC=C(C=C4)C(F)(F)F
EOS-AX0522BMS-7548071001350-96-4C23H24FN9O461.49CC1(CCCN1C2=NN3C=CC=C3C(=N2)NC4=NNC(=C4)C5CC5)C(=O)NC6=CN=C(C=C6)F
EOS-AX0523AMG-2081002304-34-8C22H17N5O2383.4COC1=CC2=NC=CC(=C2C=C1)OCC3=NN=C4N3N=C(C=C4)C5=CC=CC=C5
EOS-AX0524SGX-5231022150-57-7C18H13N7S359.41CN1C=C(C=N1)C2=NN3C(=NN=C3SC4=CC5=C(C=C4)N=CC=C5)C=C2
EOS-AX0525Levetiracetam102767-28-2C8H14N2O2170.21CCC(C(=O)N)N1CCCC1=O
EOS-AX0526Daptomycin103060-53-3C72H101N17O261620.67CCCCCCCCCC(=O)NC(CC1=CNC2=CC=CC=C21)C(=O)NC(CC(=O)N)C(=O)NC(CC(=O)O)C(=O)NC3C(OC(=O)C(NC(=O)C(NC(=O)C(NC(=O)CNC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)CNC3=O)CCCN)CC(=O)O)C)CC(=O)O)CO)C(C)CC(=O)O)CC(=O)C4=CC=CC=C4N)C
EOS-AX0527
EOS-AX0528
EOS-AX0529Lansoprazole103577-45-3C16H14F3N3O2S369.36CC1=C(C=CN=C1CS(=O)C2=NC3=CC=CC=C3N2)OCC(F)(F)F
EOS-AX0530WYE-3541062169-56-5C24H29N7O5495.53COC(=O)NC1=CC=C(C=C1)C2=NC3=C(C=NN3C4CCN(CC4)C(=O)OC)C(=N2)N5CCOCC5
EOS-AX0531Adapalene106685-40-9C28H28O3412.52COC1=C(C=C(C=C1)C2=CC3=C(C=C2)C=C(C=C3)C(=O)O)C45CC6CC(C4)CC(C6)C5
EOS-AX0532
EOS-AX0533Granisetron HCl107007-99-8C18H24N4O.HCl348.87CN1C2CCCC1CC(C2)NC(=O)C3=NN(C4=CC=CC=C43)C.Cl
EOS-AX0534Exemestane107868-30-4C20H24O2296.4CC12CCC3C(C1CCC2=O)CC(=C)C4=CC(=O)C=CC34C
EOS-AX0535GSK1904529A1089283-49-7C44H47F2N9O5S851.96CCC1=CC(=C(C=C1N2CCC(CC2)N3CCN(CC3)S(=O)(=O)C)OC)NC4=NC=CC(=N4)C5=C(N=C6N5C=CC=C6)C7=CC(=C(C=C7)OC)C(=O)NC8=C(C=CC=C8F)F
EOS-AX0536Letrozole112809-51-5C17H11N5285.3C1=CC(=CC=C1C#N)C(C2=CC=C(C=C2)C#N)N3C=NC=N3
EOS-AX0537Gatifloxacin112811-59-3C19H22FN3O4375.39CC1CN(CCN1)C2=C(C=C3C(=C2OC)N(C=C(C3=O)C(=O)O)C4CC4)F
EOS-AX0538Mosapride Citrate112885-42-4C21H25ClFN3O3.C6H8O7614.02CCOC1=CC(=C(C=C1C(=O)NCC2CN(CCO2)CC3=CC=C(C=C3)F)Cl)N.C(C(=O)O)C(CC(=O)O)(C(=O)O)O
EOS-AX0539U0126-EtOH1173097-76-1C18H16N6S2.C2H6O426.56CCO.C1=CC=C(C(=C1)N)SC(=C(C#N)C(=C(N)SC2=CC=CC=C2N)C#N)N
EOS-AX0540Zoledronic Acid118072-93-8C5H10N2O7P2272.09C1=CN(C=N1)CC(O)(P(=O)(O)O)P(=O)(O)O
EOS-AX0541Rocuronium Bromide119302-91-9C32H53N2O4.Br609.68CC(=O)OC1C(CC2C1(CCC3C2CCC4C3(CC(C(C4)O)N5CCOCC5)C)C)[N+]6(CCCC6)CC=C.[Br-]
EOS-AX0542AP261131197958-12-5C26H34ClN6O2P529.01CN(C)C1CCN(CC1)C2=CC(=C(C=C2)NC3=NC=C(C(=N3)NC4=CC=CC=C4P(=O)(C)C)Cl)OC
EOS-AX0543AZD35141240299-33-5C25H32F3N7O2519.56CC(=O)N1CCN(CC1)CCOC2=CC=C(C=C2)C3CCN(CC3)C4=NN5C(=NN=C5C(F)(F)F)CC4
EOS-AX0544Biapenem120410-24-4C15H18N4O4S350.39CC1C2C(C(=O)N2C(=C1SC3CN4C=NC=[N+]4C3)C(=O)[O-])C(C)O
EOS-AX0545Nelarabine121032-29-9C11H15N5O5297.27COC1=NC(=NC2=C1N=CN2C3C(C(C(O3)CO)O)O)N
EOS-AX0546AZD53631143532-39-1C21H25ClN6O2428.92C1CN(CCC1(C(=O)NC(CCO)C2=CC=C(C=C2)Cl)N)C3=NC=NC4=C3C=CN4
EOS-AX0547WZ40021213269-23-8C25H27ClN6O3494.18CN1CCN(CC1)C2=CC(=C(C=C2)NC3=NC=C(C(=N3)OC4=CC=CC(=C4)NC(=O)C=C)Cl)OC
EOS-AX0548WZ3146
EOS-AX0549WZ80401214265-57-2C24H25ClN6OS481.01CN1CCN(CC1)C2=CC=C(C=C2)NC3=NC=C(C(=N3)SC4=CC=CC(=C4)NC(=O)C=C)Cl
EOS-AX0550Gemcitabine HCl122111-03-9C9H11F2N3O4.HCI299.66C1=CN(C(=O)N=C1N)[C@H]2C([C@@H]([C@H](O2)CO)O)(F)F
EOS-AX0551Rigosertib (ON-01910,Estybon)1225497-78-8C21H24NNaO8S473.47COC1=C(C=C(C=C1)CS(=O)(=O)C=CC2=C(C=C(C=C2OC)OC)OC)NCC(=O)[O-].[Na+]
EOS-AX0552
EOS-AX0553Clofarabine123318-82-1C10H11ClFN5O3303.68C1=NC2=C(N1C3C(C(C(O3)CO)O)F)N=C(N=C2N)Cl
EOS-AX0554CEP-324961188910-76-0C24H22F3N5O5517.46CC(C)(C1=CC(=NO1)NC(=O)NC2=CC(=CC=C2)OC3=NC=NC4=CC(=C(C=C43)OC)OC)C(F)(F)F
EOS-AX0555Losartan Potassium (DuP 753)124750-99-8C22H23ClKN6O462.01CCCCC1=NC(=C(N1CC2=CC=C(C=C2)C3=CC=CC=C3C4=NN=N[N-]4)CO)Cl.[K+]
EOS-AX0556
EOS-AX0557Fulvestrant (ICI 182,780)129453-61-8C32H47F5O3S606.77CC12CCC3C(C1CCC2O)C(CC4=C3C=CC(=C4)O)CCCCCCCCCS(=O)CCCC(C(F)(F)F)(F)F
EOS-AX0558CP-945598 HCl686347-12-6C25H25Cl2N7O.HCl546.88CCNC1(CCN(CC1)C2=NC=NC3=C2N=C(N3C4=CC=C(C=C4)Cl)C5=CC=CC=C5Cl)C(=O)N.Cl
EOS-AX0559Cilnidipine132203-70-4C27H28N2O7492.52CC1=C(C(C(=C(N1)C)C(=O)OCC=CC2=CC=CC=C2)C3=CC(=CC=C3)[N+](=O)[O-])C(=O)OCCOC
EOS-AX0560Lidocaine137-58-6C14H22N2O234.34CCN(CC)CC(=O)NC1=C(C=CC=C1C)C
EOS-AX0561ABT-751 (E7010)141430-65-1C18H17N3O4S371.41COC1=CC=C(C=C1)S(=O)(=O)NC2=C(N=CC=C2)NC3=CC=C(C=C3)O
EOS-AX0562
EOS-AX05637-Methoxycoumarin-4-acetyl-P-L-G-L-β-(2,4-dinitrophenylamino)A-R amide140430-53-1C49H68N14O151093.15COC1=CC=C(C(CC(N2CCC[C@@H]2C(N[C@H](CC(C)C)C(NCC(N[C@H](CC(C)C)C(NC([C@H](C(N[C@@H](C(N[C@@H](C(N)=O)CCCNC(N)=N)=O)C)=O)N)C3=CC=C([N+]([O-])=O)C=C3[N+]([O-])=O)=O)=O)=O)=O)=O)=CC(O4)=O)C4=C1
EOS-AX0564Mca-Pro-Leu-NH2C23H29N3O6443.49C1=CC=C2C=C(C(=CC2=C1)C(=O)NNC=C3C=CC(=O)C(=C3)O)O
EOS-AX0565Dexrazoxane HCl (ICRF-187, ADR-529)149003-01-0C11H16N4O4.HCl304.73CC(CN1CC(=O)NC(=O)C1)N2CC(=O)NC(=O)C2.Cl
EOS-AX0566Dynasore304448-55-3C18H14N2O4322.31OC1=C(C(N/N=C/C(C=C2)=CC(O)=C2O)=O)C=C(C=CC=C3)C3=C1
EOS-AX0567L-a-Hydroxyglutaric acid disodium salt63512-50-5C5H6Na2O5192.08O=C([O-])[C@@H](O)CCC([O-])=O.[Na+].[Na+]
EOS-AX0568Prasugrel150322-43-3C20H20FNO3S373.44CC(=O)OC1=CC2=C(S1)CCN(C2)C(C3=CC=CC=C3F)C(=O)C4CC4
EOS-AX0569GANT61500579-04-4C27H35N5429.6CN(C)C1=CC=CC=C1CN2CCCN(C2C3=CC=NC=C3)CC4=CC=CC=C4N(C)C
EOS-AX0570Epothilone A152044-53-6C26H39NO6S493.66CC1CCCC2C(O2)CC(OC(=O)CC(C(C(=O)C(C1O)C)(C)C)O)C(=CC3=CSC(=N3)C)C
EOS-AX0571Zaragozic Acid A142561-96-4C35H46O14690.73O[C@@H]1[C@H]([C@@]2([C@](C(O)=O)([C@H](O[C@@]1(CCC([C@H]([C@@H](CC3=CC=CC=C3)C)OC(C)=O)=C)O2)C(O)=O)O)C(O)=O)OC(/C=C/[C@H](C[C@H](CC)C)C)=O
EOS-AX0572Epothilone B (EPO906, Patupilone)152044-54-7C27H41NO6S507.68CC1CCCC2(C(O2)CC(OC(=O)CC(C(C(=O)C(C1O)C)(C)C)O)C(=CC3=CSC(=N3)C)C)C
EOS-AX0573SB202190 (FHPI)152121-30-7C20H14N3OF331.34C1=CC(=O)C=CC1=C2NC(=C(N2)C3=CC=NC=C3)C4=CC=C(C=C4)F
EOS-AX0574GDC-03491207360-89-1C24H32N6O3452.55CCNC(=O)NC1=CC=C(C=C1)C2=NC3=C(CCN(C3)C4COC4)C(=N2)N5CCOCC5C
EOS-AX0575Dimesna16208-51-8C4H8Na2O6S4326.34C(CS(=O)(=O)[O-])SSCCS(=O)(=O)[O-].[Na+].[Na+]
EOS-AX0576GW2580870483-87-7C20H22N4O3366.41COC1=CC=C(C=C1)COC2=C(C=C(C=C2)CC3=CN=C(N=C3N)N)OC
EOS-AX0577Dutasteride164656-23-9C27H30F6N2O2528.53CC12CCC3C(C1CCC2C(=O)NC4=C(C=CC(=C4)C(F)(F)F)C(F)(F)F)CCC5C3(C=CC(=O)N5)C
EOS-AX0578PD98059167869-21-8C16H13NO3267.28COC1=CC=CC(=C1N)C2=CC(=O)C3=CC=CC=C3O2
EOS-AX0579Celecoxib169590-42-5C17H14F3N3O2S381.37CC1=CC=C(C=C1)C2=CC(=NN2C3=CC=C(C=C3)S(=O)(=O)N)C(F)(F)F
EOS-AX0580Enzastaurin (LY317615)170364-57-5C32H29N5O2515.61CN1C=C(C2=CC=CC=C21)C3=C(C(=O)NC3=O)C4=CN(C5=CC=CC=C54)C6CCN(CC6)CC7=CC=CC=N7
EOS-AX0581Aprepitant170729-80-3C23H21F7N4O3534.43CC(C1=CC(=CC(=C1)C(F)(F)F)C(F)(F)F)OC2C(N(CCO2)CC3=NC(=O)NN3)C4=CC=C(C=C4)F
EOS-AX0582GW9508885101-89-3C22H21NO3347.41C1=CC=C(C=C1)OC2=CC=CC(=C2)CNC3=CC=C(C=C3)CCC(=O)O
EOS-AX0583Posaconazole171228-49-2C37H42F2N8O4700.78CCC(C(C)O)N1C(=O)N(C=N1)C2=CC=C(C=C2)N3CCN(CC3)C4=CC=C(C=C4)OCC5CC(OC5)(CN6C=NC=N6)C7=C(C=C(C=C7)F)F
EOS-AX0584IPI-145 (INK1197)1201438-56-3C22H17ClN6O416.86CC(C1=CC2=C(C(=CC=C2)Cl)C(=O)N1C3=CC=CC=C3)NC4=NC=NC5=C4NC=N5
EOS-AX0585PD153035 HCl
EOS-AX0586Roscovitine (Seliciclib,CYC202)186692-46-6C19H26N6O354.45CCC(CO)NC1=NC2=C(C(=N1)NCC3=CC=CC=C3)N=CN2C(C)C
EOS-AX0587PA-824187235-37-6C14H12F3N3O5359.26C1C(COC2=NC(=CN21)[N+](=O)[O-])OCC3=CC=C(C=C3)OC(F)(F)F
EOS-AX0588Galanthamine HBr1953-04-4C17H21NO3.HBr368.27COC1=CC=C2C3=C1O[C@]4([H])[C@]3(C=C[C@H](O)C4)CCN(C)C2.Br
EOS-AX0589Ramelteon196597-26-9C16H21NO2259.34CCC(=O)NCCC1CCC2=C1C3=C(C=C2)OCC3
EOS-AX0590Tenofovir Disoproxil Fumarate202138-50-9C19H30N5O10P.C4H4O4635.51CC(C)OC(=O)OCOP(=O)(COC(C)CN1C=NC2=C1N=CN=C2N)OCOC(=O)OC(C)C.C(=CC(=O)O)C(=O)O
EOS-AX0591Vincristine sulfate2068-78-2C46H58N4O14S923.04O[C@]1(CC)CN(CC2)C[C@@](C1)([H])C[C@](C(OC)=O)(C3=C(OC)C=C(N(C=O)[C@]4([H])[C@@]56C7[C@](C=CCN7CC6)(CC)C(OC(C)=O)[C@@]4(C(OC)=O)O)C5=C3)C8=C2C9=CC=CC=C9N8.OS(O)(=O)=O
EOS-AX0592Entecavir Hydrate209216-23-9C12H15N5O3.H2O295.29C=C1C(CC(C1CO)O)N2C=NC3=C2NC(=NC3=O)N.O
EOS-AX0593KU-0060648881375-00-4C33H34N4O4S582.71CCN1CCN(CC1)CC(=O)NC2=C3C4=CC=CC=C4SC3=C(C=C2)C5=CC=CC6=C5OC(=CC6=O)N7CCOCC7
EOS-AX0594Vatalanib (PTK787) 2HCl212141-51-0C20H15ClN4.2HCl419.73C1=CC=C2C(=C1)C(=NN=C2NC3=CC=C(C=C3)Cl)CC4=CC=NC=C4.Cl.Cl
EOS-AX0595PD184352 (CI-1040)212631-79-3C17H14ClF2IN2O2478.67C1CC1CONC(=O)C2=C(C(=C(C=C2)F)F)NC3=C(C=C(C=C3)I)Cl
EOS-AX0596LY28352191231930-82-7C27H32F2N8.CH4O3S602.7CCN1CCN(CC1)CC2=CN=C(C=C2)NC3=NC=C(C(=N3)C4=CC5=C(C(=C4)F)N=C(N5C(C)C)C)F.CS(=O)(=O)O
EOS-AX0597Mianserin HCl21535-47-7C18H20N2.HCl300.83CN1CC2C3=C(C=CC=C3)CC4=C(C=CC=C4)N2CC1.Cl
EOS-AX0598Imatinib Mesylate (STI571)220127-57-1C29H31N7O.CH4SO3589.71CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5.CS(=O)(=O)O
EOS-AX0599Ki8751228559-41-9C24H18F3N3O4469.41COC1=CC2=C(C=CN=C2C=C1OC)OC3=CC(=C(C=C3)NC(=O)NC4=C(C=C(C=C4)F)F)F
EOS-AX0600Doxorubicin (Adriamycin) HCl25316-40-9C27H29NO11.HCl579.98CC1C(C(CC(O1)OC2CC(CC3=C(C4=C(C(=C23)O)C(=O)C5=C(C4=O)C=CC=C5OC)O)(C(=O)CO)O)N)O.Cl
EOS-AX0601Pelitinib (EKB-569)257933-82-7C24H23ClFN5O2467.92CCOC1=C(C=C2C(=C1)N=CC(=C2NC3=CC(=C(C=C3)F)Cl)C#N)NC(=O)C=CCN(C)C
EOS-AX0602Canertinib (CI-1033)267243-28-7C24H25ClFN5O3485.94C=CC(=O)NC1=C(C=C2C(=C1)C(=NC=N2)NC3=CC(=C(C=C3)F)Cl)OCCCN4CCOCC4
EOS-AX0603Bumetanide28395-03-1C17H20N2O5S364.42CCCCNC1=C(C(=CC(=C1)C(=O)O)S(=O)(=O)N)OC2=CC=CC=C2
EOS-AX0604XAV-939284028-89-3C14H11F3N2OS312.31C1CSCC2=C1NC(=NC2=O)C3=CC=C(C=C3)C(F)(F)F
EOS-AX0605Cediranib (AZD217)288383-20-0C25H27FN4O3450.51CC1=CC2=C(N1)C=CC(=C2F)OC3=NC=NC4=CC(=C(C=C43)OC)OCCCN5CCCC5
EOS-AX0606TRAM-34289905-88-0C22H17ClN2344.84C1=CC=C(C=C1)C(C2=CC=CC=C2)(C3=CC=CC=C3Cl)N4C=CC=N4
EOS-AX0607SL-327305350-87-2C16H12F3N3S335.35C1=CC=C(C(=C1)C(=C(N)SC2=CC=C(C=C2)N)C#N)C(F)(F)F
EOS-AX0608PSI158442-41-2C32H50N4O8618.76CCC(C)C(C(=O)NC(CCC(=O)OC(C)(C)C)C(=O)NC(C)C(=O)NC(CC(C)C)C=O)NC(=O)OCC1=CC=CC=C1
EOS-AX0609Q-VD-OPh hydrate1135695-98-5C26H25F2N3O6.xH2O513.49CC(C)C(C(=O)NC(CC(=O)O)C(=O)COC1=C(C=CC=C1F)F)NC(=O)C2=NC3=CC=CC=C3C=C2
EOS-AX0610Z-VAD-FMK187389-52-2C22H30FN3O7467.49CC(C)C(C(=O)NC(C)C(=O)NC(CC(=O)OC)C(=O)CF)NC(=O)OCC1=CC=CC=C1
EOS-AX0611E 64d88321-09-9C17H30N2O5342.43CCOC(=O)C1C(O1)C(=O)NC(CC(C)C)C(=O)NCCC(C)C
EOS-AX0612Boc-D-FMK187389-53-3;634911-80-1C11H18FNO5263.26CC(C)(C)OC(=O)NC(CC(=O)OC)C(=O)CF
EOS-AX06133-Deazaneplanocin,DZNep102052-95-9C12H24N4O3262.26C1=CN=C(C2=C1N(C=N2)C3C=C(C(C3O)O)CO)N
EOS-AX0614Decitabine (NSC127716, 5AZA-CdR)2353-33-5C8H12N4O4228.08C1C(C(OC1N2C=NC(=NC2=O)N)CO)O
EOS-AX06155-Azacytidine320-67-2C8H12N4O5244.2C1=NC(=NC(=O)N1C2C(C(C(O2)CO)O)O)N
EOS-AX0616AMI-1C21H12N2O9S2Na4592.42C1=CC2=C(C=C(C=C2C=C1NC(=O)NC3=CC4=CC(=CC(=C4C=C3)[O-])S(=O)(=O)[O-])S(=O)(=O)[O-])[O-].[Na+].[Na+].[Na+].[Na+]
EOS-AX0617BIX 01294935693-62-2C28H38N6O2490.65CN1CCCN(CC1)C2=NC3=CC(=C(C=C3C(=N2)NC4CCN(CC4)CC5=CC=CC=C5)OC)OC
EOS-AX0618Bromodomain Inhibitor, (+)-JQ11268524-70-4C23H25ClN4O2S456.99CC1=C(C)SC2=C1C(C3=CC=C(Cl)C=C3)=N[C@@H](CC(OC(C)(C)C)=O)C4=NN=C(C)N24
EOS-AX0619EZSolution  (+)-JQ11268524-70-4C23H25ClN4O2S456.99
EOS-AX0620Lomeguatrib192441-08-0C10H8BrN5OS326.17C1=C(SC=C1Br)COC2=NC(=NC3=C2NC=N3)N
EOS-AX0621RG 10848208-26-0C19H14N2O4334.33C1=CC=C2C(=C1)C(=O)N(C2=O)C(CC3=CNC4=CC=CC=C43)C(=O)O
EOS-AX0622UNC06381255580-76-7C30H47N5O2509.72CC(C)N1CCC(CC1)NC2=NC(=NC3=CC(=C(C=C32)OC)OCCCN4CCCC4)C5CCCCC5
EOS-AX0623Zebularine3690-10-6C9H12N2O5228.2C1=CN(C(=O)N=C1)C2C(C(C(O2)CO)O)O
EOS-AX0624Z-DEVD-FMK210344-95-9C30H41N4O12F668.66CC(C)C(C(=O)NC(CC(=O)OC)C(=O)CF)NC(=O)C(CCC(=O)OC)NC(=O)C(CC(=O)OC)NC(=O)OCC1=CC=CC=C1
EOS-AX0625Z-DQMD-FMKC29H40FN5O11S685.72COC(=O)CC(C(=O)CF)NC(=O)C(CCSC)NC(=O)C(CCC(=O)N)NC(=O)C(CC(=O)OC)NC(=O)OCC1=CC=CC=C1
EOS-AX0626Z-VDVAD-FMKC32H46N5O11F695.73CC(C)C(C(=O)NC(C)C(=O)NC(CC(=O)OC)C(=O)CF)NC(=O)C(CC(=O)OC)NC(=O)C(C(C)C)NC(=O)OCC1=CC=CC=C1
EOS-AX0627Z-VEID-FMKC31H45FN4O10652.71CCC(C)C(C(=O)NC(CC(=O)OC)C(=O)CF)NC(=O)C(CCC(=O)OC)NC(=O)C(C(C)C)NC(=O)OCC1=CC=CC=C1
EOS-AX0628Z-WEHD-FMK210345-00-9C37H42FN7O10763.77COC(=O)CCC(C(=O)NC(CC1=CN=CN1)C(=O)NC(CC(=O)OC)C(=O)CF)NC(=O)C(CC2=CNC3=CC=CC=C32)NC(=O)OCC4=CC=CC=C4
EOS-AX0629Caspase-3/7 Inhibitor I220509-74-0C14H16N2O5S324.4COCC1CCCN1S(=O)(=O)C2=CC3=C(C=C2)NC(=O)C3=O
EOS-AX0630CA 074134448-10-5C18H29N3O6383.44CCCNC(=O)C1C(O1)C(=O)NC(C(C)CC)C(=O)N2CCCC2C(=O)O
EOS-AX0631Macitentan441798-33-0C19H20Br2N6O4S588.27CCCNS(=O)(=O)NC1=C(C(=NC=N1)OCCOC2=NC=C(C=N2)Br)C3=CC=C(C=C3)Br
EOS-AX0632Apoptosis Inhibitor54135-60-3C13H16O4236.3C1CC(=O)C(C(=O)C1)CC2C(=O)CCCC2=O
EOS-AX0633Pyronaridine Tetraphosphate76748-86-2C29H32ClN5O24H3PO4910.03COC1=CC=C2C(=C(C3=C(N2)C=C(C=C3)Cl)N=C4C=C(C(=O)C(=C4)CN5CCCC5)CN6CCCC6)N1.OP(=O)(O)O.OP(=O)(O)O.OP(=O)(O)O.OP(=O)(O)O
EOS-AX0634(-)-Huperzine A102518-79-6C15H18N2O242.3C/C=C1[C@@]2(N)C3=C(NC(C=C3)=O)C[C@]/1([H])C=C(C)C2
EOS-AX0635Carfilzomib (PR-171)868540-17-4C40H57N5O7719.91CC(C)CC(C(=O)C1(CO1)C)NC(=O)C(CC2=CC=CC=C2)NC(=O)C(CC(C)C)NC(=O)C(CCC3=CC=CC=C3)NC(=O)CN4CCOCC4
EOS-AX0636Oprozomib (ONX-0912)935888-69-0C25H32N4O7S532.61CC1=NC=C(S1)C(=O)NC(COC)C(=O)NC(COC)C(=O)NC(CC2=CC=CC=C2)C(=O)C3(CO3)C
EOS-AX06375-Aminovaleric acid hydrochloride660-88-8C5H11NO2117.15O=C(O)CCCCN
EOS-AX0638BIBR 1532321674-73-1C21H17NO3331.36CC(=CC(=O)NC1=CC=CC=C1C(=O)O)C2=CC3=CC=CC=C3C=C2
EOS-AX0639MEK162 (ARRY-162, ARRY-438162)606143-89-9C17H15BrF2N4O3441.23CN1C=NC2=C1C=C(C(=C2F)NC3=C(C=C(C=C3)Br)F)C(=O)NOCCO
EOS-AX0640NSC 237661177865-17-6C24H35N7.3HCl530.96CCN(CC)CCCC(C)NC1=NC(=CC(=N1)NC2=CC3=C(C=C2)N=C(C=C3N)C)C
EOS-AX0641Etomidate33125-97-2C14H16N2O2244.29CCOC(=O)C1=CN=CN1C(C)C2=CC=CC=C2
EOS-AX0642
EOS-AX0643Etoposide33419-42-0C29H32O13588.56CC1OCC2C(O1)C(C(C(O2)OC3C4COC(=O)C4C(C5=CC6=C(C=C35)OCO6)C7=CC(=C(C(=C7)OC)O)OC)O)O
EOS-AX0644SNS-032 (BMS-387032)345627-80-7C17H24N4O2S2380.53CC(C)(C)C1=CN=C(O1)CSC2=CN=C(S2)NC(=O)C3CCNCC3
EOS-AX0645Bendamustine HCl3543-75-7C16H21Cl2N3O2.HCl394.72CN1C2=C(C=C(C=C2)N(CCCl)CCCl)N=C1CCCC(=O)O.Cl
EOS-AX0646Nu 6027220036-08-8C11H17N5O2251.28C1CCC(CC1)COC2=NC(=NC(=C2N=O)N)N
EOS-AX0647Ki16425355025-24-0C23H23ClN2O5S474.96CC1=NOC(=C1NC(=O)OC(C)C2=CC=CC=C2Cl)C3=CC=C(C=C3)CSCCC(=O)O
EOS-AX0648Nutlin-3b675576-97-3C30H30Cl2N4O4581.49CC(C)OC1=C(C=CC(=C1)OC)C2=NC(C(N2C(=O)N3CCNC(=O)C3)C4=CC=C(C=C4)Cl)C5=CC=C(C=C5)Cl
EOS-AX0649PD168393194423-15-9C17H13BrN4O369.22C=CC(=O)NC1=CC2=C(C=C1)N=CN=C2NC3=CC(=CC=C3)Br
EOS-AX0650Plerixafor (AMD3100)110078-46-1C28H54N8502.78C1CNCCNCCCN(CCNC1)CC2=CC=C(C=C2)CN3CCCNCCNCCCNCC3
EOS-AX0651PQ 401196868-63-0C18H16ClN3O2341.79CC1=NC2=CC=CC=C2C(=C1)NC(=O)NC3=C(C=CC(=C3)Cl)OC
EOS-AX0652Doripenem Hydrate364622-82-2C15H24N4O6S2.H2O438.52CC1C2C(C(=O)N2C(=C1SC3CC(NC3)CNS(=O)(=O)N)C(=O)O)C(C)O.O
EOS-AX0653IC-87114371242-69-2C22H19N7O397.43CC1=C2C(=CC=C1)N=C(N(C2=O)C3=CC=CC=C3C)CN4C=NC5=C4N=CN=C5N
EOS-AX0654PI-103371935-74-9C19H16N4O3348.36C1COCCN1C2=NC(=NC3=C2OC4=C3C=CC=N4)C5=CC(=CC=C5)O
EOS-AX0655PIK-75372196-77-5C16H14BrN5O4S.HCl488.74CC1=C(C=C(C=C1)[N+](=O)[O-])S(=O)(=O)N(C)N=CC2=CN=C3N2C=C(C=C3)Br.Cl
EOS-AX0656Ifosfamide3778-73-2C7H15Cl2N2O2P261.09C1CN(P(=O)(OC1)NCCCl)CCCl
EOS-AX0657PRX-08066 Maleic acid866206-55-5C19H17ClFN5S.C4H4O4517.96FC(C=C1)=C(C#N)C=C1CN(CC2)CCC2NC3=C(C=C(Cl)S4)C4=NC=N3.O=C(O)/C=C\C(O)=O
EOS-AX0658Saracatinib (AZD0530)379231-04-6C27H32ClN5O5542.03CN1CCN(CC1)CCOC2=CC(=C3C(=C2)N=CN=C3NC4=C(C=CC5=C4OCO5)Cl)OC6CCOCC6
EOS-AX0659Bosutinib (SKI-606)380843-75-4C26H29Cl2N5O3530.45CN1CCN(CC1)CCCOC2=C(C=C3C(=C2)N=CC(=C3NC4=CC(=C(C=C4Cl)Cl)OC)C#N)OC
EOS-AX0660Andarine401900-40-1C19H18F3N3O6441.36C(=O)NC1=CC=C(C=C1)OCC(C)(C(=O)NC2=CC(=C(C=C2)[N+](=O)[O-])C(F)(F)F)O
EOS-AX0661Dovitinib (TKI-258, CHIR-258)405169-16-6C21H21FN6O392.43CN1CCN(CC1)C2=CC3=C(C=C2)NC(=C4C(=C5C(=NC4=O)C=CC=C5F)N)N3
EOS-AX0662Carboplatin41575-94-4C6H12N2O4Pt371.25C1CC(C1)(C(=O)[O-])C(=O)[O-].N.N.[Pt+2]
EOS-AX0663SC 144895158-95-9C16H11FN6O322.3FC1=CC(N=C(NNC(C2=NC=CN=C2)=O)C3=CC=CN34)=C4C=C1
EOS-AX0664Lenvatinib (E7080)417716-92-8C21H19ClN4O4426.85COC1=CC2=NC=CC(=C2C=C1C(=O)N)OC3=CC(=C(C=C3)NC(=O)NC4CC4)Cl
EOS-AX0665Cladribine4291-63-8C10H12ClN5O3285.69C1C(C(OC1N2C=NC3=C2N=C(N=C3N)Cl)CO)O
EOS-AX0666Dacarbazine4342-03-4C6H10N6O182.18CN(C)NN=C1C(=NC=N1)C(=O)N
EOS-AX0667Genistein446-72-0C15H10O5270.24C1=CC(=CC=C1C2=COC3=CC(=CC(=C3C2=O)O)O)O
EOS-AX066817-DMAG (Alvespimycin) HCl467214-21-7C32H48N4O8.HCl653.21CC1CC(C(C(C=C(C(C(C=CC=C(C(=O)NC2=CC(=O)C(=C(C1)C2=O)NCCN(C)C)C)OC)OC(=O)N)C)C)O)OC.Cl
EOS-AX0669Stattic19983-44-9C8H5NO4S211.19C1=CC(=CC2=C1C=CS2(=O)=O)[N+](=O)[O-]
EOS-AX0670BMS-536924468740-43-4C25H26ClN5O3479.96CC1=CC(=CC2=C1NC(=C3C(=CC=NC3=O)NCC(C4=CC(=CC=C4)Cl)O)N2)N5CCOCC5
EOS-AX0671T0901317293754-55-9C17H12F9NO3S481.33C1=CC=C(C=C1)S(=O)(=O)N(CC(F)(F)F)C2=CC=C(C=C2)C(C(F)(F)F)(C(F)(F)F)O
EOS-AX0672Tivozanib (AV-951)475108-18-0C22H19ClN4O5454.86CC1=CC(=NO1)NC(=O)NC2=C(C=C(C=C2)OC3=C4C=C(C(=CC4=NC=C3)OC)OC)Cl
EOS-AX0673NVP-AEW541475489-16-8C27H29N5O439.55C1CN(C1)CC2CC(C2)N3C=C(C4=C3N=CN=C4N)C5=CC(=CC=C5)OCC6=CC=CC=C6
EOS-AX0674Ellagic acid476-66-4C14H6O8302.19OC1=C(O)C2=C3C(C(OC4=C3C(C(O2)=O)=CC(O)=C4O)=O)=C1
EOS-AX0675PHA-665752477575-56-7C32H34Cl2N4O4S641.61CC1=C(NC(=C1C(=O)N2CCCC2CN3CCCC3)C)C=C4C5=C(C=CC(=C5)S(=O)(=O)CC6=C(C=CC=C6Cl)Cl)NC4=O
EOS-AX0676TAK-4381260141-27-2C17H16FN3O2S.C4H4O4461.46CNCC1=CN(C(=C1)C2=CC=CC=C2F)S(=O)(=O)C3=CN=CC=C3.C(=CC(=O)O)C(=O)O
EOS-AX0677SR90091379686-30-2C20H24ClN3O4S437.94CCOC(N1CCC(C1)CN(CC(S2)=CC=C2[N+]([O-])=O)CC3=CC=C(Cl)C=C3)=O
EOS-AX0678TCS 359301305-73-7C18H20N2O4S360.43COC1=C(C=C(C=C1)C(=O)NC2=C(C3=C(S2)CCCC3)C(=O)N)OC
EOS-AX0679Dexamethasone (DHAP)50-02-2C22H29FO5392.46O=C1C=C[C@@]2(C)C(CC[C@@]3([H])[C@]2(F)[C@@H](O)C[C@@]4(C)[C@@]3([H])C[C@@H](C)[C@@]4(C(CO)=O)O)=C1
EOS-AX0680Cyclophosphamide50-18-0C7H15Cl2N2O2P261.09C1CNP(=O)(OC1)N(CCCl)CCCl
EOS-AX0681Mercaptopurine (6-MP)50-44-2C5H4N4S152.18C1=NC2=C(N1)C(=S)N=CN2
EOS-AX0682Floxuridine50-91-9C9H11FN2O5246.19C1C(C(OC1N2C=C(C(=O)NC2=O)F)CO)O
EOS-AX0683CP-724714537705-08-1C27H27N5O3469.53CC1=NC=C(C=C1)OC2=C(C=C(C=C2)NC3=NC=NC4=C3C=C(C=C4)C=CCNC(=O)COC)C
EOS-AX0684Acitretin55079-83-9C21H26O3326.43CC1=CC(=C(C(=C1C=CC(=CC=CC(=CC(=O)O)C)C)C)C)OC
EOS-AX0685Acarbose56180-94-0C25H43NO18645.6CC1C(C(C(C(O1)OC2C(OC(C(C2O)O)OC3C(OC(C(C3O)O)O)CO)CO)O)O)NC4C=C(C(C(C4O)O)O)CO
EOS-AX0686Fluoxetine HCl56296-78-7C17H18F3NO.HCl345.79CNCCC(C1=CC=CC=C1)OC2=CC=C(C=C2)C(F)(F)F.Cl
EOS-AX0687Epirubicin HCl56390-09-1C27H29NO11.HCl579.98CC1C(C(CC(O1)OC2CC(CC3=C(C4=C(C(=C23)O)C(=O)C5=C(C4=O)C=CC=C5OC)O)(C(=O)CO)O)N)O.Cl
EOS-AX0688Pamidronate Disodium57248-88-1C3H9NNa2O7P2279.03C(CN)C(O)(P(=O)(O)[O-])P(=O)(O)[O-].[Na+].[Na+]
EOS-AX0689Idarubicin HCl57852-57-0C26H27NO9.HCl533.95CC1C(C(CC(O1)OC2CC(CC3=C(C4=C(C(=C23)O)C(=O)C5=CC=CC=C5C4=O)O)(C(=O)C)O)N)O.Cl
EOS-AX0690Tyrphostin AG 1296146535-11-7C16H14N2O2266.29COC1=C(C=C2C(=C1)N=CC(=N2)C3=CC=CC=C3)OC
EOS-AX0691Malotilate59937-28-9C12H16O4S2288.38CC(C)OC(=O)C(=C1SC=CS1)C(=O)OC(C)C
EOS-AX0692Odanacatib (MK-0822)603139-19-1C25H27F4N3O3S525.56CC(C)(CC(C(=O)NC1(CC1)C#N)NC(C2=CC=C(C=C2)C3=CC=C(C=C3)S(=O)(=O)C)C(F)(F)F)F
EOS-AX0693Leucovorin Calcium6035-45-6C21H25CaN7O7.5H2O601.58C1C(N(C2=C(N1)NC(=NC2=O)N)C=O)CNC3=CC=C(C=C3)C(=O)NC(CCC(=O)[O-])C(=O)[O-].O.O.O.O.O.[Ca+2]
EOS-AX0694Agarose GPG/LE9012-36-6O=C(C)C1=CC=C(CCCCCC)C=C1
EOS-AX0695Agarose GPG/LMP low melt9012-36-6
EOS-AX0696Agarose GPG/ME9012-36-6
EOS-AX0697Agarose, Resolute GPG9012-36-6
EOS-AX0698Supra Sieve GPG
EOS-AX0699Ampicillin69-52-3C16H18N3NaO4S371.4CC1(C(N2C(S1)C(C2=O)NC(=O)C(C3=CC=CC=C3)N)C(=O)[O-])C.[Na+]
EOS-AX0700Carbenicillin, Disodium Salt4800-94-6C17H16N2O6SNa2422.4CC1(C(N2C(S1)C(C2=O)NC(=O)C(C3=CC=CC=C3)C(=O)[O-])C(=O)[O-])C.[Na+].[Na+]
EOS-AX0701Chloramphenicol56-75-7C11H12Cl2N2O5323.13C1=CC(=CC=C1C(C(CO)NC(=O)C(Cl)Cl)O)[N+](=O)[O-]
EOS-AX0702Geneticin, G-418 Sulfate108321-42-2C20H40N4O10.2H2SO4692.71CC(C1C(C(C(C(O1)OC2C(CC(C(C2O)OC3C(C(C(CO3)(C)O)NC)O)N)N)N)O)O)O.OS(=O)(=O)O.OS(=O)(=O)O
EOS-AX0703Gentamycin Sulfate1405-41-0C21H45N5O11S1488.78CC(C1CCC(C(O1)OC2C(CC(C(C2O)OC3C(C(C(CO3)(C)O)NC)O)N)N)N)NC.OS(=O)(=O)O
EOS-AX0704Hygromycin B31282-04-9C20H37N3O13527.5CNC1CC(C(C(C1O)OC2C3C(C(C(O2)CO)O)OC4(O3)C(C(C(C(O4)C(CO)N)O)O)O)O)N
EOS-AX0705Kanamycin Sulfate25389-94-0C18H36N4O11.H2SO4582.58C1C(C(C(C(C1N)OC2C(C(C(C(O2)CN)O)O)O)O)OC3C(C(C(C(O3)CO)O)N)O)N.OS(=O)(=O)O
EOS-AX0706Tetracycline Hydrochloride64-75-5C22H25ClN2O8480.9CC1(C2CC3C(C(=O)C(=C(C3(C(=O)C2=C(C4=C1C=CC=C4O)O)O)O)C(=O)N)N(C)C)O.Cl
EOS-AX0707VE-8211232410-49-9C18H16N4O3S368.41CS(=O)(=O)C1=CC=C(C=C1)C2=CN=C(C(=N2)C(=O)NC3=CC=CC=C3)N
EOS-AX0708Agar (bacteriological)9002-18-0CC1C(C2C(C(O1)CO2)OC3C(C(C(C(O3)CO)O)OC)O)O
EOS-AX0709Fluoroorotic Acid, Ultra Pure703-95-7C5H3FN2O4.H2O192.11C1(=C(NC(=O)NC1=O)C(=O)O)F
EOS-AX0710LB Agar Miller
EOS-AX0711LB Broth, Lennox
EOS-AX0712LB Broth, Miller
EOS-AX0713Peptone, bacteriological
EOS-AX0714TB Dry
EOS-AX0715TB Dry, Sterile Solution
EOS-AX0716TryptoneC=CC(N([H])[H])=[o]
EOS-AX0717X-Gal7240-90-6C14H15BrCINO6408.63C1=CC(=C(C2=C1NC=C2OC3C(C(C(C(O3)CO)O)O)O)Cl)Br
EOS-AX0718Yeast Extract8013-1-2
EOS-AX0719 YT Broth, 2X liquid 
EOS-AX0720YT Broth, 2X powder blend
EOS-AX0721Vortioxetine (Lu AA21004) HBr960203-27-4C18H22N2S.HBr379.36CC1=CC(=C(C=C1)SC2=CC=CC=C2N3CCNCC3)C.Br
EOS-AX0722Carmofur61422-45-5C11H16FN3O3257.26CCCCCCNC(=O)N1C=C(C(=O)NC1=O)F
EOS-AX0723Adenosine-5-triphosphate, disodium salt987-65-5C10H14N5O13P3Na2551.15
EOS-AX0724
EOS-AX0725Quercetin dihydrate6151-25-3C15H10O7.2H2O338.27C1=CC(=C(C=C1C2=C(C(=O)C3=C(C=C(C=C3O2)O)O)O)O)O.O.O
EOS-AX0726Fluvoxamine maleate61718-82-9C14H18F3N2O2.C4H4O4434.41COCCCCC(=NOCCN)C1=CC=C(C=C1)C(F)(F)F.C(=CC(=O)O)C(=O)O
EOS-AX0727Altretamine645-05-6C9H18N6210.28CN(C)C1=NC(=NC(=N1)N(C)C)N(C)C
EOS-AX0728R(-)-Apomorphine41372-20-7C17H20ClNO3321.8CN1CCC2=C([C@@]1([H])CC3=C4C(O)=C(O)C=C3)C4=CC=C2.Cl.O
EOS-AX0729Leupeptin, Microbial103476-89-7C20H38N6O4.1/2H2SO4493.6O=C(C(C([H])([H])C(C([H])([H])[H])([H])C([H])([H])[H])([H])N([H])C(C([H])([H])[H])=O)N([H])C(C(N([H])C(C([H])=O)([H])C([H])([H])C([H])([H])C([H])([H])/N=C(N([H])[H])/N([H])[H])=O)([H])C([H])([H])C(C([H])([H])[H])([H])C([H])([H])[H]
EOS-AX0730Pepstatin A26305-03-3C34H63N5O9685.9CC(C)CC(C(CC(=O)O)O)NC(=O)C(C)NC(=O)CC(C(CC(C)C)NC(=O)C(C(C)C)NC(=O)C(C(C)C)NC(=O)CC(C)C)O
EOS-AX0731dNTP Mix, 100mM
EOS-AX0732AEBSF.HCl30827-99-7C8H10FNO2S.HCl239.69C1=CC(=CC=C1CCN)S(=O)(=O)F.Cl
EOS-AX0733Aprotinin9087-70-1C284H432N84O79S76511.44CC(O)=O.CC.CC.CCccC.[R].[P].[2H].[L].[E].[P].[P].[Y].[3H].[G].[KH].[R].[R].[Y].F.[Y].[*].[L].F.[V].[Y].[G].[G].[R].[KH].[R].N.N.F.[KH].S.[*].[2H].[R].[G].[G].[*].[KH].[*].[3H].C.[*].F.[P].[*].I.I.N.[Q].[3H].[M]
EOS-AX0734Bestatin58970-76-6C16H24N2O4308.37CC(C)CC(C(=O)O)NC(=O)C(C(CC1=CC=CC=C1)N)O
EOS-AX0735E-6466701-25-5C15H27N5O5357.41CC(C)CC(C(=O)NCCCCN=C(N)N)NC(=O)C1C(O1)C(=O)O
EOS-AX0736Batimastat (BB-94)130370-60-4C23H31N3O4S2477.64CNC([C@@H](NC([C@@H]([C@H](CSC1=CC=CS1)C(NO)=O)CC(C)C)=O)CC2=CC=CC=C2)=O
EOS-AX0737Clasto-Lactacystin β-lactone154226-60-5C10H15NO4213.23CC1C2C(C(=O)O2)(NC1=O)C(C(C)C)O
EOS-AX0738Elastase Inhibitor111682-13-4C20H31ClN4O7474.94CC(C(=O)CCl)NC(=O)C1CCCN1C(=O)C(C)NC(=O)C(C)NC(=O)CCC(=O)OC
EOS-AX0739Elastase Inhibitor, SPCK65144-34-5C22H35ClN4O7503CC(C)C(C(=O)CCl)NC(=O)C1CCCN1C(=O)C(C)NC(=O)C(C)NC(=O)CCC(=O)OC
EOS-AX0740EZSolution  MG-132133407-82-6C26H41N3O5475.6
EOS-AX0741GGACK DihydrochlorideC14H25ClN6O5.2HCl465.76ClC([H])([H])C([C@@](C([H])([H])C([H])([H])C([H])([H])/N=C(N([H])[H])/N([H])[H])([H])N([H])C(C([H])([H])N([H])C([C@@](C([H])([H])C([H])([H])C(O[H])=O)([H])N([H])[H])=O)=O)=O.Cl.Cl
EOS-AX0742Lactacystin (Synthetic)133343-34-7C15H24N2O7S376.42CC1C(C(NC1=O)(C(C(C)C)O)C(=O)SCC(C(=O)O)NC(=O)C)O
EOS-AX0743MG-132133407-82-6C26H41N3O5475.6CC(C)CC(C=O)NC(=O)C(CC(C)C)NC(=O)C(CC(C)C)NC(=O)OCC1=CC=CC=C1
EOS-AX0744Nafamostat Mesylate(FUT-175)82956-11-4C19H17N5O2.2CH4O3S539.59CS(=O)(=O)O.CS(=O)(=O)O.C1=CC(=CC=C1C(=O)OC2=CC3=C(C=C2)C=C(C=C3)C(=N)N)N=C(N)N
EOS-AX0745PMSF329-98-6C7H7FO2S174.2C1=CC=C(C=C1)CS(=O)(=O)F
EOS-AX0746PPACK DihydrochlorideC21H31ClN6O3.2HCl523.88C1CC(N(C1)C(CCCN=C(N)N)C(=O)CCl)C(=O)NC(=O)C(CC2=CC=CC=C2)N
EOS-AX0747Vicriviroc Malate541503-81-5C28H38F3N5O2.C4H6O5667.72CC1CN(CCN1C(COC)C2=CC=C(C=C2)C(F)(F)F)C3(CCN(CC3)C(=O)C4=C(N=CN=C4C)C)C.C(C(C(=O)O)O)C(=O)O
EOS-AX0748Brivanib (BMS-540215)649735-46-6C19H19FN4O3370.38CC1=CC2=C(N1)C=CC(=C2F)OC3=NC=NN4C3=C(C(=C4)OCC(C)O)C
EOS-AX0749(-)-Epigallocatechin gallate (EGCG)989-51-5C22H18O11458.37C1C(C(OC2=CC(=CC(=C21)O)O)C3=CC(=C(C(=C3)O)O)O)OC(=O)C4=CC(=C(C(=C4)O)O)O
EOS-AX0750Aclacinomycin A57576-44-0C42H53NO15811.87OC1=CC=CC(C(C2=C3C(O)=C4C([C@@H](C(OC)=O)[C@@](O)(CC)C[C@@H]4O[C@H]5C[C@H](N(C)C)[C@H](O[C@@H]6O[C@@H](C)[C@@H](O[C@@H]7O[C@@H](C)C(CC7)=O)[C@@H](O)C6)[C@H](C)O5)=C2)=O)=C1C3=O
EOS-AX0751Calpain Inhibitor I, ALLN110044-82-1C20H37N3O4383.54CCCCC(C=O)NC(=O)C(CC(C)C)NC(=O)C(CC(C)C)NC(=O)C
EOS-AX0752Calpain Inhibitor II, ALLM136632-32-1C19H35N3O4S401.57CC(C)CC(C(=O)NC(CC(C)C)C(=O)NC(CCSC)C=O)NC(=O)C
EOS-AX0753Celastrol34157-83-0C29H38O4450.61CC1=C(C(=O)C=C2C1=CC=C3C2(CCC4(C3(CCC5(C4CC(CC5)(C)C(=O)O)C)C)C)C)O
EOS-AX0754Epoxomicin134381-21-8C28H50N4O7554.7CCC(C)C(C(=O)NC(C(C)O)C(=O)NC(CC(C)C)C(=O)C1(CO1)C)NC(=O)C(C(C)CC)N(C)C(=O)C
EOS-AX0755EZSolution  MG-115C25H39N3O5461.59
EOS-AX0756EZSolution  PS-341179324-69-7C19H25BN4O4384.24
EOS-AX0757Fenbendazole43210-67-9C15H13N3O2S299.35COC(=O)NC1=NC2=C(N1)C=C(C=C2)SC3=CC=CC=C3
EOS-AX0758MG-115133407-86-0C25H39N3O5461.59CCCC(C=O)NC(=O)C(CC(C)C)NC(=O)C(CC(C)C)NC(=O)OCC1=CC=CC=C1
EOS-AX0759Bortezomib (PS-341)179324-69-7C19H25BN4O4384.24B(C(CC(C)C)NC(=O)C(CC1=CC=CC=C1)NC(=O)C2=NC=CN=C2)(O)O
EOS-AX0760VU 03644391246086-78-1C18H13Cl2N3O3S422.29C1=CC=C(C(=C1)NS(=O)(=O)C2=C(C=C(C=C2)NC(=O)C3=CC=CC=N3)Cl)Cl
EOS-AX0761Brivanib Alaninate (BMS-582664)649735-63-7C22H24FN5O4441.46CC1=CC2=C(N1)C=CC(=C2F)OC3=NC=NN4C3=C(C(=C4)OCC(C)OC(=O)C(C)N)C
EOS-AX0762VX-6611152311-62-0C26H27F3N2O6520.5CC(C)(CO)C1=CC2=CC(=C(C=C2N1CC(CO)O)F)NC(=O)C3(CC3)C4=CC5=C(C=C4)OC(O5)(F)F
EOS-AX0763AG-102465678-07-1C14H13BrN2O305.17CC(C)(C)C1=C(C(=CC(=C1)C=C(C#N)C#N)Br)O
EOS-AX0764SU11274658084-23-2C28H30CIN5O4S568.09CC1=C(NC(=C1C(=O)N2CCN(CC2)C)C)C=C3C4=C(C=CC(=C4)S(=O)(=O)N(C)C5=CC(=CC=C5)Cl)NC3=O
EOS-AX0765TGX-221663619-89-4C21H24N4O2364.44CC1=CN2C(=O)C=C(N=C2C(=C1)C(C)NC3=CC=CC=C3)N4CCOCC4
EOS-AX0766Butein487-52-5C15H12O5272.25C1=CC(=C(C=C1C=CC(=O)C2=C(C=C(C=C2)O)O)O)O
EOS-AX076710Panx955091-53-9C58H79N15O161242.37CC(C)C(C(=O)NC(CC(=O)O)C(=O)NC(CO)C(=O)NC(CC1=CC=C(C=C1)O)C(=O)O)NC(=O)C(CC2=CC=CC=C2)NC(=O)C(C)NC(=O)C(C)NC(=O)C(CCC(=O)N)NC(=O)C(CCCN=C(N)N)NC(=O)C(CC3=CNC4=CC=CC=C43)N
EOS-AX0768Scrambled 10Panx1315378-72-3C58H79N15O161242.37CC(C)C(C(=O)NC(CC1=CC=C(C=C1)O)C(=O)NC(CC2=CNC3=CC=CC=C32)C(=O)NC(C)C(=O)NC(CCC(=O)N)C(=O)NC(C)C(=O)NC(CC(=O)O)C(=O)NC(CCCN=C(N)N)C(=O)O)NC(=O)C(CO)NC(=O)C(CC4=CC=CC=C4)N
EOS-AX0769TG100-115677297-51-7C18H14N6O2346.34C1=CC(=CC(=C1)O)C2=NC3=C(N=C2C4=CC(=CC=C4)O)N=C(N=C3N)N
EOS-AX0770PIK-90677338-12-4C18H17N5O3351.36COC1=C(C2=C(C=C1)C3=NCCN3C(=N2)NC(=O)C4=CN=CC=C4)OC
EOS-AX0771Amonafide69408-81-7C16H17N3O2283.33CN(C)CCN1C(=O)C2=CC=CC3=CC(=CC(=C32)C1=O)N
EOS-AX0772BX-912702674-56-4C20H23BrN8O471.35C1CCN(C1)C(=O)NC2=CC=CC(=C2)NC3=NC=C(C(=N3)NCCC4=CN=CN4)Br
EOS-AX0773Ivermectin70288-86-7C48H74O14875.09C/C([C@@H](O[C@H]1C[C@H](OC)[C@@H](O[C@H]2C[C@H](OC)[C@@H](O)[C@H](C)O2)[C@H](C)O1)[C@@H](C)/C=C/C=C(CO3)/[C@@]([C@@]3([H])[C@H](O)C(C)=C4)(O)[C@@H]4C5=O)=C\C[C@@H]6C[C@H](O5)C[C@@]7(O[C@@]([C@@H](C)CC)([H])[C@@H](C)CC7)O6
EOS-AX0774AC480 (BMS-599626)714971-09-2C27H27FN8O3.HCl567.01CC1=C2C(=NC=NN2C=C1NC(=O)OCC3COCCN3)NC4=CC5=C(C=C4)N(N=C5)CC6=CC(=CC=C6)F
EOS-AX0775OSI-930728033-96-3C22H16F3N3O2S443.44C1=CC=C2C(=C1)C(=CC=N2)CNC3=C(SC=C3)C(=O)NC4=CC=C(C=C4)OC(F)(F)F
EOS-AX0776Melatonin73-31-4C13H16N2O2232.28CC(=O)NCCC1=CNC2=C1C=C(C=C2)OC
EOS-AX0777Omeprazole73590-58-6C17H19N3O3S345.42CC1=CN=C(C(=C1OC)C)CS(=O)C2=NC3=C(N2)C=C(C=C3)OC
EOS-AX0778OSU-03012 (AR-12)742112-33-0C26H19F3N4O460.45C1=CC=C2C(=C1)C=CC3=C2C=CC(=C3)C4=CC(=NN4C5=CC=C(C=C5)NC(=O)CN)C(F)(F)F
EOS-AX0779Leflunomide75706-12-6C12H9F3N2O2270.21CC1=C(C=NO1)C(=O)NC2=CC=C(C=C2)C(F)(F)F
EOS-AX0780Camptothecin7689-03-4C20H16N2O4348.35O=C(N(CC1=CC(C=CC=C2)=C2N=C13)C3=C4)C(CO5)=C4[C@@](O)(CC)C5=O
EOS-AX0781Doxazosin Mesylate77883-43-3C23H25N5O5.CH4O3S547.58COC1=C(C=C2C(=C1)C(=NC(=N2)N3CCN(CC3)C(=O)C4COC5=CC=CC=C5O4)N)OC.CS(=O)(=O)O
EOS-AX0782Nepafenac78281-72-8C15H14N2O2254.28C1=CC=C(C=C1)C(=O)C2=C(C(=CC=C2)CC(=O)N)N
EOS-AX0783Flumazenil78755-81-4C15H14FN3O3303.29CCOC(=O)C1=C2CN(C(=O)C3=C(N2C=N1)C=CC(=C3)F)C
EOS-AX0784Masitinib (AB1010)790299-79-5C28H30N6OS498.64CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC(=CS4)C5=CN=CC=C5
EOS-AX0785Linifanib (ABT-869)796967-16-3C21H18FN5O375.41CC1=CC(=C(C=C1)F)NC(=O)NC2=CC=C(C=C2)C3=C4C(=CC=C3)NN=C4N
EOS-AX0786Loratadine79794-75-5C22H23ClN2O2382.88CCOC(=O)N1CCC(=C2C3=C(CCC4=C2N=CC=C4)C=C(C=C3)Cl)CC1
EOS-AX0787MK-2866 (GTx-024)
EOS-AX0788Foretinib (GSK1363089)849217-64-7C34H34F2N4O6632.65COC1=CC2=C(C=CN=C2C=C1OCCCN3CCOCC3)OC4=C(C=C(C=C4)NC(=O)C5(CC5)C(=O)NC6=CC=C(C=C6)F)F
EOS-AX0789Cabozantinib (XL184, BMS-907351)849217-68-1C28H24FN3O5501.51COC1=CC2=C(C=CN=C2C=C1OC)OC3=CC=C(C=C3)NC(=O)C4(CC4)C(=O)NC5=CC=C(C=C5)F
EOS-AX0790ADL5859 HCl850173-95-4C24H28N2O3.HCl428.95CCN(CC)C(=O)C1=CC=C(C=C1)C2=CC3(CCNCC3)OC4=C2C(=CC=C4)O.Cl
EOS-AX0791PCI-32765 (Ibrutinib)936563-96-1C25H24N6O2440.5C=CC(=O)N1CCCC(C1)N2C3=C(C(=N2)C4=CC=C(C=C4)OC5=CC=CC=C5)C(=NC=N3)N
EOS-AX0792ABT-888 (Veliparib)912444-00-9C13H16N4O 244.3CC1(CCCN1)C2=NC3=C(C=CC=C3N2)C(=O)N
EOS-AX0793MDV3100 (Enzalutamide)915087-33-1C21H16F4N4O2S464.4CC1(C(=O)N(C(=S)N1C2=CC(=C(C=C2)C(=O)NC)F)C3=CC(=C(C=C3)C#N)C(F)(F)F)C
EOS-AX0794Vemurafenib (PLX4032, RG7204)918504-65-1C23H18ClF2N3O3S489.93CCCS(=O)(=O)NC1=C(C(=C(C=C1)F)C(=O)C2=CNC3=NC=C(C=C23)C4=CC=C(C=C4)Cl)F
EOS-AX0795CAL-101 (Idelalisib, GS-1101)870281-82-6C22H18FN7O415.43CCC(C1=NC2=C(C(=CC=C2)F)C(=O)N1C3=CC=CC=C3)NC4=NC=NC5=C4NC=N5
EOS-AX0796GDC-0068 (RG7440)1001264-89-6C24H32ClN5O2458CC1CC(C2=C1C(=NC=N2)N3CCN(CC3)C(=O)C(CNC(C)C)C4=CC=C(C=C4)Cl)O
EOS-AX0797ABT-263 (Navitoclax)923564-51-6C47H55ClF3N5O6S3974.61CC(CC1)(C)CC(CN2CCN(C3=CC=C(C(NS(C4=CC=C(N[C@@H](CSC5=CC=CC=C5)CCN6CCOCC6)C(S(C(F)(F)F)(=O)=O)=C4)(=O)=O)=O)C=C3)CC2)=C1C7=CC=C(Cl)C=C7
EOS-AX0798Y-27632 dihydrochloride146986-50-7;129830-38-2C14H21N3O.2HCl320.26CC(C1CCC(CC1)C(=O)NC2=CC=NC=C2)N
EOS-AX0799Sorafenib284461-73-0C21H16ClF3N4O3464.82CNC(=O)C1=NC=CC(=C1)OC2=CC=C(C=C2)NC(=O)NC3=CC(=C(C=C3)Cl)C(F)(F)F
EOS-AX0800MK-2206 dihydrochloride1032350-13-2C25H21N5O.2HCl480.39C1CC(C1)(C2=CC=C(C=C2)C3=C(C=C4C(=N3)C=CN5C4=NNC5=O)C6=CC=CC=C6)N.Cl.Cl
EOS-AX0801CHIR-99021 (CT99021)252917-06-9C22H18Cl2N8465.34CC1=CN=C(N1)C2=CN=C(N=C2C3=C(C=C(C=C3)Cl)Cl)NCCNC4=NC=C(C=C4)C#N
EOS-AX0802Ruxolitinib (INCB018424)941678-49-5C17H18N6306.37C1CCC(C1)C(CC#N)N2C=C(C=N2)C3=C4C=CNC4=NC=N3
EOS-AX0803PD0325901391210-10-9C16H14F3IN2O4482.19C1=CC(=C(C=C1I)F)NC2=C(C=CC(=C2F)F)C(=O)NOCC(CO)O
EOS-AX0804BGJ398872511-34-7C26H31Cl2N7O3560.48CCN1CCN(CC1)C2=CC=C(C=C2)NC3=CC(=NC=N3)N(C)C(=O)NC4=C(C(=CC(=C4Cl)OC)OC)Cl
EOS-AX0805BKM120944396-07-0C18H21F3N6O2410.39C1COCCN1C2=NC(=NC(=C2)C3=CN=C(C=C3C(F)(F)F)N)N4CCOCC4
EOS-AX0806PLX-4720918505-84-7C17H14ClF2N3O3S413.83CCCS(=O)(=O)NC1=C(C(=C(C=C1)F)C(=O)C2=CNC3=NC=C(C=C23)Cl)F
EOS-AX0807Dasatinib (BMS-354825)302962-49-8C22H26ClN7O2S488.01CC1=C(C(=CC=C1)Cl)NC(=O)C2=CN=C(S2)NC3=NC(=NC(=C3)N4CCN(CC4)CCO)C
EOS-AX0808Trametinib (GSK1120212)871700-17-3C26H23FIN5O4615.39CC1=C2C(=C(N(C1=O)C)NC3=C(C=C(C=C3)I)F)C(=O)N(C(=O)N2C4=CC(=CC=C4)NC(=O)C)C5CC5
EOS-AX0809AT-406 (SM-406)1071992-99-8C32H43N5O4561.71CC(CC(N(C[C@@](/N=C(O)/[C@](NC)([H])C)([H])C1=O)CC[C@@](N21)([H])CC[C@@]2([H])/C(O)=N/C(C3=CC=CC=C3)C4=CC=CC=C4)=O)C
EOS-AX0810(R)-Crizotinib877399-52-5C21H22Cl2FN5O450.34CC(C1=C(C=CC(=C1Cl)F)Cl)OC2=C(N=CC(=C2)C3=CN(N=C3)C4CCNCC4)N
EOS-AX0811GDC-0449 (Vismodegib)879085-55-9C19H14Cl2N2O3S 421.3CS(=O)(=O)C1=CC(=C(C=C1)C(=O)NC2=CC(=C(C=C2)Cl)C3=CC=CC=N3)Cl
EOS-AX0812Pazopanib (GW-786034)444731-52-6C21H23N7O2S 437.52CC1=C(C=C(C=C1)NC2=NC=CC(=N2)N(C)C3=CC4=NN(C(=C4C=C3)C)C)S(=O)(=O)N.Cl
EOS-AX0813P005091882257-11-6C12H7Cl2NO3S2348.22CC(=O)C1=CC(=C(S1)SC2=C(C(=CC=C2)Cl)Cl)[N+](=O)[O-]
EOS-AX0814(+)-MK 80170449-94-4C16H15N221.3C[C@]1(N2)C3=C(C=CC=C3)C[C@@H]2C4=C1C=CC=C4
EOS-AX0815(24R)-MC 976112828-09-8C27H42O3414.62CC(CCC(C1CC1)O)C2CCC3C2(CCCC3=CC=C4CC(CC(C4=C)O)O)C
EOS-AX0816(24S)-24,25-Dihydroxyvitamin D355700-58-8C27H44O3416.64CC(CCC(C(C)(C)O)O)C1CCC2C1(CCCC2=CC=C3CC(CCC3=C)O)C
EOS-AX0817(24S)-MC 976112849-14-6C27H42O3414.62CC(CCC(C1CC1)O)C2CCC3C2(CCCC3=CC=C4CC(CC(C4=C)O)O)C
EOS-AX0818(E)-2-Decenoic acid334-49-6C10H18O2170.25CCCCCCCC=CC(=O)O
EOS-AX0819(R,R)-Formoterol67346-49-0C19H24N2O4344.4CC(NCC(O)C1=CC(NC=O)=C(O)C=C1)CC2=CC=C(OC)C=C2
EOS-AX0820(S)-Tedizolid1431699-67-0C17H15FN6O3370.34CN1N=C(N=N1)C2=NC=C(C=C2)C3=C(C=C(C=C3)N4CC(OC4=O)CO)F
EOS-AX0821(Z)-2-decenoic acid15790-91-7C10H18O2170.25CCCCCCC/C=C\C(O)=O
EOS-AX082217 alpha-propionate19608-29-8C24H34O5402.52CCC(=O)OC1(CCC2C1(CCC3C2CCC4=CC(=O)CCC34C)C)C(=O)CO
EOS-AX082317-AAG Hydrochloride911710-03-7C31H44ClN3O8622.15CC1CC(C(C(C=C(C(C(C=CC=C(C(=O)NC2=CC(=O)C(=C(C1)C2=O)NCC=C)C)OC)OC(=O)N)C)C)O)OC.Cl
EOS-AX08241alpha, 24, 25-Trihydroxy VD2457048-34-9C28H44O4444.65CC(C=CC(C)(C(C)(C)O)O)C1CCC2C1(CCCC2=CC=C3CC(CC(C3=C)O)O)C
EOS-AX08251alpha, 25-Dihydroxy VD2-D6216244-04-1C28H38D6O3428.65O[C@H]1C[C@H](O)C(/C(C1)=C\C=C2[C@]3([H])CC[C@H]([C@@H](/C=C/[C@H](C)C(C([2H])([2H])[2H])(O)C([2H])([2H])[2H])C)[C@@]3(C)CCC\2)=C
EOS-AX08261alpha-Hydroxy VD4143032-85-3C28H46O2414.66CC(C)C(C)CCC(C)C1CCC2C1(CCCC2=CC=C3CC(CC(C3=C)O)O)C
EOS-AX082720-HETE79551-86-3C20H32O3320.47C(CCC=CCC=CCC=CCC=CCCCC(=O)O)CCO
EOS-AX082824, 25-Dihydroxy VD258050-55-8C28H44O3428.65CC(C=CC(C)(C(C)(C)O)O)C1CCC2C1(CCCC2=CC=C3CC(CCC3=C)O)C
EOS-AX082924, 25-Dihydroxy VD340013-87-4C27H44O3416.64CC(CCC(C(C)(C)O)O)C1CCC2C1(CCCC2=CC=C3CC(CCC3=C)O)C
EOS-AX083024R-Calcipotriol112827-99-3C27H40O3412.6CC(C=CC(C1CC1)O)C2CCC3C2(CCCC3=CC=C4CC(CC(C4=C)O)O)C
EOS-AX083125-Hydroxy VD2-D61262843-46-8C28H38D6O2418.68O[C@@H]1C/C(C(CC1)=C)=C/C=C2[C@]3([H])CC[C@H]([C@@H](/C=C/[C@H](C)C(C([2H])([2H])[2H])(O)C([2H])([2H])[2H])C)[C@@]3(C)CCC/2
EOS-AX08323,3'-Diindolylmethane1968-05-4C17H14N2246.31C1=CC=C2C(=C1)C(=CN2)CC3=CNC4=CC=CC=C43
EOS-AX0833360A794458-56-3C27H23N5O2 2+449.5CN1=C2C=CC=CC2=C/C(C=1)=[NH+]/C(C3=NC(C(/[NH+]=C4C=C5C=CC=CC5=N(C)=C/4)=O)=CC=C3)=O
EOS-AX0834360A iodide737763-37-0C27H23I2N5O2703.31CN1=C2C=CC=CC2=C/C(C=1)=N/C(C3=NC(C(/N=C4C=C5C=CC=CC5=N(C)=C/4)=O)=CC=C3)=O.I.I
EOS-AX08353-O-(2-Aminoethyl)-25-hydroxyvitamin D3163018-26-6C30H51NO2457.73CC(CCCC(C)(C)O)C1CCC2C1(CCCC2=CC=C3CC(CCC3=C)OCCCN)C
EOS-AX0836PI4KIII beta inhibitor 31245319-54-3C22H22N8OS446.53CC1=CC=C(C=C1)NC(=O)N2CCN(CC2)C3=C4C(=NC(=N3)N)SC(=N4)C5=CN=CC=C5
EOS-AX08374'-Demethylepipodophyllotoxin6559-91-7C21H20O8400.38COC1=CC(=CC(=C1O)OC)C2C3C(COC3=O)C(C4=CC5=C(C=C24)OCO5)O
EOS-AX08385-hydroxypyrazine-2-carboxylic acid34604-60-9C5H4N2O3140.1OC1=NC=C(C(O)=O)N=C1
EOS-AX08395-Iodotubercidin24386-93-4C11H13IN4O4392.15C1=C(C2=C(N1C3C(C(C(O3)CO)O)O)N=CN=C2N)I
EOS-AX08405-R-Rivaroxaban865479-71-6C19H18ClN3O5S435.88C1COCC(=O)N1C2=CC=C(C=C2)N3CC(OC3=O)CNC(=O)C4=CC=C(S4)Cl
EOS-AX08417-Epi 10-Desacetyl Paclitaxel78454-17-8C45H49NO13811.87CC1=C2C(C(=O)C3(C(CC4C(C3C(C(C2(C)C)(CC1OC(=O)C(C(C5=CC=CC=C5)NC(=O)C6=CC=CC=C6)O)O)OC(=O)C7=CC=CC=C7)(CO4)OC(=O)C)O)C)O
EOS-AX08427-xylosyltaxol90332-66-4C52H59NO18986.02CC1=C2C(C(=O)C3(C(CC4C(C3C(C(C2(C)C)(CC1OC(=O)C(C(C5=CC=CC=C5)NC(=O)C6=CC=CC=C6)O)O)OC(=O)C7=CC=CC=C7)(CO4)OC(=O)C)OC8C(C(C(CO8)O)O)O)C)OC(=O)C
EOS-AX08439-Dihydro-13-acetylbaccatin III142203-65-4C33H42O12630.68CC1=C2C(C(C3(C(CC4C(C3C(C(C2(C)C)(CC1OC(=O)C)O)OC(=O)C5=CC=CC=C5)(CO4)OC(=O)C)O)C)O)OC(=O)C
EOS-AX0844A 438079899507-36-9C13H9Cl2N5306.15C1=CC(=C(C(=C1)Cl)Cl)C2=NN=NN2CC3=CN=CC=C3.Cl
EOS-AX0845A 438079 hydrochloride899431-18-6C13H10Cl3N5342.61C1=CC(=C(C(=C1)Cl)Cl)C2=NN=NN2CC3=CN=CC=C3.Cl
EOS-AX0846A 77-01607737-87-1C18H14N4286.33CC1=CC=CC(=N1)C2=C(C=NN2)C3=CC=NC4=CC=CC=C34
EOS-AX0847A 83-01909910-43-6C25H19N5S421.52CC1=CC=CC(=N1)C2=NN(C=C2C3=CC=NC4=CC=CC=C34)C(=S)NC5=CC=CC=C5
EOS-AX0848A-317491475205-49-3C33H27NO8565.57C1CC(C2=CC=CC=C2C1)N(CC3=CC(=CC=C3)OC4=CC=CC=C4)C(=O)C5=CC(=C(C=C5C(=O)O)C(=O)O)C(=O)O
EOS-AX0849A-443654552325-16-3C24H23N5O397.48CC1=C2C=C(C=CC2=NN1)C3=CC(=CN=C3)OCC(CC4=CNC5=CC=CC=C54)N
EOS-AX0850A-740003861393-28-4C26H30N6O3474.57CC(C)(C)C(NC(=O)CC1=CC(=C(C=C1)OC)OC)N=C(NC#N)NC2=CC=CC3=C2C=CC=N3
EOS-AX0851A-770041869748-10-7C34H39N9O3621.75CC(N1CCN([C@@]2([H])CC[C@@](N3C4=NC=NC(N)=C4C(C5=CC(OC)=C(/N=C(O)/C6=CC7=CC=CC=C7N6C)C=C5)=N3)([H])CC2)CC1)=O
EOS-AX0852A-8677441000279-69-5C20H19ClN2O3S402.89CCC(=O)C1=C(N(C(=C1)C2=CC=C(C=C2)Cl)C3=CC=C(C=C3)S(=O)(=O)N)C
EOS-AX0853Abacavir136470-78-5C14H18N6O286.33C1CC1NC2=NC(=NC3=C2N=CN3C4CC(C=C4)CO)N
EOS-AX0854ABT-0461031336-60-3C20H22N4O2350.41NC1=C(C2=CC=C([C@@]3([H])CC[C@@](CC(O)=O)([H])CC3)C=C2)C=NC4=CC=NN41
EOS-AX0855ABT-1991257044-40-8C45H50ClN7O7S868.44
EOS-AX0856Acamprosate calcium77337-73-6C10H20CaN2O8S2400.48CC(=O)NCCCS(=O)(=O)[O-].CC(=O)NCCCS(=O)(=O)[O-].[Ca+2]
EOS-AX0857Adarotene496868-77-0C25H26O3374.47C1C2CC3CC1CC(C2)(C3)C4=C(C=CC(=C4)C5=CC=C(C=C5)C=CC(=O)O)O
EOS-AX0858Adoprazine222551-17-9C24H24FN3O2405.46C1CN(CCN1CC2=CN=CC(=C2)C3=CC=C(C=C3)F)C4=C5C(=CC=C4)OCCO5
EOS-AX0859Afatinib dimaleate850140-73-7C32H33ClFN5O11718.08CN(C)CC=CC(=O)NC1=C(C=C2C(=C1)C(=NC=N2)NC3=CC(=C(C=C3)F)Cl)OC4CCOC4.C(=CC(=O)O)C(=O)O.C(=CC(=O)O)C(=O)O
EOS-AX0860AGI-67801432660-47-3C21H18F3N3O3S2481.51C1CC1NS(=O)(=O)C2=CC(=C(C=C2)C3=CSC=C3)NC(=O)NC4=CC=CC(=C4)C(F)(F)F
EOS-AX0861AH 680933458-93-4C17H14O5298.29CC(C)OC1=CC2=C(C=C1)C(=O)C3=C(O2)C=CC(=C3)C(=O)O
EOS-AX0862AIM-100873305-35-2C23H21N3O2371.43C1CC(OC1)CNC2=C3C(=C(OC3=NC=N2)C4=CC=CC=C4)C5=CC=CC=C5
EOS-AX0863AKT inhibitor VIII612847-09-3C34H29N7O551.64C1CN(CCC1N2C3=CC=CC=C3NC2=O)CC4=CC=C(C=C4)C5=NC6=CC7=C(C=C6N=C5C8=CC=CC=C8)N=CN7
EOS-AX0864AKT Kinase Inhibitor842148-40-7C16H19N7O3357.37CCN1C2=C(C(=NC=C2OCCCN)C#CCO)N=C1C3=NON=C3N
EOS-AX0865Alarelin Acetate79561-22-1C60H86N16O161287.42CC/N=C(O)/[C@]1([H])CCCN1C([C@](/N=C(O)/[C@](/N=C(O)/[C@@](/N=C(O)/[C@](/N=C(O)/[C@](/N=C(O)/[C@](/N=C(O)/[C@](/N=C(O)/C2([H])CCC(O)=N2)([H])CC3=CN=CN3)([H])CC4=CNC5=CC=CC=C45)([H])CO)([H])CC6=CC=C(O)C=C6)([H])C)([H])CC(C)C)([H])CCCNC(N)=N)=O.CC(O)=O.CC(O
EOS-AX0866Aleglitazar475479-34-6C24H23NO5S437.51CC1=C(N=C(O1)C2=CC=CC=C2)CCOC3=C4C=CSC4=C(C=C3)CC(C(=O)O)OC
EOS-AX0867Aliskiren173334-57-1C30H53N3O6551.77CC(C)C(CC1=CC(=C(C=C1)OC)OCCCOC)CC(C(CC(C(C)C)C(=O)NCC(C)(C)C(=O)N)O)N
EOS-AX0868ALK inhibitor 1761436-81-1C23H28BrN7O3S562.48CNS(=O)(=O)C1=CC=CC=C1NC2=NC(=NC=C2Br)NC3=C(C=C(C=C3)N4CCN(CC4)C)OC
EOS-AX0869ALK inhibitor 2761438-38-4C23H28ClN7O3S518.03CNS(=O)(=O)C1=CC=CC=C1NC2=NC(=NC=C2Cl)NC3=C(C=C(C=C3)N4CCN(CC4)C)OC
EOS-AX0870Alogliptin Benzoate850649-62-6C25H27N5O4461.51CN1C(=O)C=C(N(C1=O)CC2=CC=CC=C2C#N)N3CCCC(C3)N.C1=CC=C(C=C1)C(=O)O
EOS-AX0871Alosetron122852-42-0C17H18N4O294.35CC1=C(N=CN1)CN2CCC3=C(C2=O)C4=CC=CC=C4N3C
EOS-AX0872Alosetron (Z)-2-butenedioate122852-43-1C21H22N4O5410.42CC(N=CN1)=C1CN2CCC3=C(C2=O)C4=CC=CC=C4N3C.O=C(O)/C([H])=C([H])\C(O)=O
EOS-AX0873Alosetron Hydrochloride122852-69-1C17H19ClN4O330.81CC1=C(N=CN1)CN2CCC3=C(C2=O)C4=CC=CC=C4N3C.Cl
EOS-AX0874Alosetron Hydrochloride(1:X)132414-02-9C17H19ClN4O330.81CC(N=CN1)=C1CN2CCC3=C(C2=O)C4=CC=CC=C4N3C.Cl
EOS-AX0875Alvespimycin467214-20-6C32H48N4O8616.75CC1CC(C(C(C=C(C(C(C=CC=C(C(=O)NC2=CC(=O)C(=C(C1)C2=O)NCCN(C)C)C)OC)OC(=O)N)C)C)O)OC
EOS-AX0876Alvimopan156053-89-3C25H32N2O4424.53C[C@@]1([H])CN(C[C@](/C(O)=N/CC(O)=O)([H])CC2=CC=CC=C2)CC[C@]1(C3=CC(O)=CC=C3)C
EOS-AX0877Alvimopan dihydrate170098-38-1C25H36N2O6460.56CC1CN(CCC1(C)C2=CC(=CC=C2)O)CC(CC3=CC=CC=C3)C(=O)NCC(=O)O.O.O
EOS-AX0878Alvimopan monohydrate1383577-62-5C25H34N2O5442.55CC1CN(CCC1(C)C2=CC(=CC=C2)O)CC(CC3=CC=CC=C3)C(=O)NCC(=O)O.O
EOS-AX0879ALW-II-41-271186206-79-0C32H32F3N5O2S607.69CCN1CCN(CC2=C(C(F)(F)F)C=C(NC(C3=CC(NC(C4=CN=CC(C5=CC=CS5)=C4)=O)=C(C=C3)C)=O)C=C2)CC1
EOS-AX0880AM0951345614-59-6C27H23N2NaO5478.47CC1=NOC(=C1NC(=O)OC(C)C2=CC=CC=C2)C3=CC=C(C=C3)C4=CC=C(C=C4)CC(=O)[O-].[Na+]
EOS-AX0881AM-095 free base1228690-36-5C27H24N2O5456.49CC1=NOC(=C1NC(=O)OC(C)C2=CC=CC=C2)C3=CC=C(C=C3)C4=CC=C(C=C4)CC(=O)O
EOS-AX0882AM630164178-33-0C23H25IN2O3504.36CC1=C(C2=C(N1CCN3CCOCC3)C=C(C=C2)I)C(=O)C4=CC=C(C=C4)OC
EOS-AX0883AM6791206880-66-1C40H44N4O5S692.87CC(=O)N1C(CC2=CC=CC=C21)COC3=CC4=C(C=C3)N(C(=C4SC(C)(C)C)CC(C)(C)C(=O)O)CC5=CC=C(C=C5)C6=NC=C(C=N6)OC
EOS-AX0884AM9661228690-19-4C27H23ClN2O5490.93CC1=NOC(=C1NC(=O)OC(C)C2=CC=CC=C2Cl)C3=CC=C(C=C3)C4=CC=C(C=C4)CC(=O)O
EOS-AX0885Amadacycline389139-89-3C29H40N4O7556.65CC(C)(CNCC1=CC(N(C)C)=C(C2=C1O)C[C@@](C(C2=O)=C(O)[C@@]34O)([H])C[C@@]3([H])[C@@](N(C)C)([H])C(O)=C(C(O)=N)C4=O)C
EOS-AX0886Amadacycline methanesulfonate1196800-40-4C30H44N4O10S652.76CN(C)C1=CC(CNCC(C)(C)C)=C(O)C(C2=O)=C1C[C@@H]3C2=C(O)[C@@](C(C(C(N)=O)=C(O)[C@H]4N(C)C)=O)(O)[C@H]4C3.OS(C)(=O)=O
EOS-AX0887AMD-070558447-26-0C21H27N5349.48C1CC(C2=C(C1)C=CC=N2)N(CCCCN)CC3=NC4=CC=CC=C4N3
EOS-AX0888AMD-070 hydrochloride880549-30-4C21H30Cl3N5458.86C1CC(C2=C(C1)C=CC=N2)N(CCCCN)CC3=NC4=CC=CC=C4N3.Cl
EOS-AX0889Amineptine57574-09-1C22H27NO2337.46
EOS-AX0890Ampalex154235-83-3C14H15N3O241.29C1CCN(CC1)C(=O)C2=CC3=NC=CN=C3C=C2
EOS-AX0891AN-2690174671-46-6C7H6BFO2151.93B1(C2=C(CO1)C=C(C=C2)F)O
EOS-AX0892AN-2728906673-24-3C14H10BNO3251.05N#CC1=CC=C(OC2=CC=C3C(COB3O)=C2)C=C1
EOS-AX0893Anamorelin249921-19-5C31H42N6O3546.7CC(C)(C(=O)NC(CC1=CNC2=CC=CC=C21)C(=O)N3CCCC(C3)(CC4=CC=CC=C4)C(=O)N(C)N(C)C)N
EOS-AX0894Anamorelin Fumarate339539-92-3C35H46N6O7662.78CC(/C(O)=N/[C@](C(N1CCC[C@@](C1)(C(N(N(C)C)C)=O)CC2=CC=CC=C2)=O)([H])CC3=CNC4=CC=CC=C34)(N)C.O=C(O)/C([H])=C([H])/C(O)=O
EOS-AX0895Anamorelin hydrochloride861998-00-7C31H43ClN6O3583.16CC(/C(O)=N/[C@](C(N1CCC[C@@](C1)(C(N(N(C)C)C)=O)CC2=CC=CC=C2)=O)([H])CC3=CNC4=CC=CC=C34)(N)C.Cl
EOS-AX0896Anguizole442666-98-0C17H11ClF2N4O2S408.81C1=COC(=C1)C2=NC3=CC(=NN3C(=C2)C(F)(F)Cl)C(=O)NCC4=CC=CS4
EOS-AX0897Ansamitocin P-366547-09-9C32H43ClN2O9635.14CCCC(O[C@@]([C@]1([C@@](O1)([H])[C@]([C@](O2)([H])C[C@](N=C2O)(O)[C@@](OC)([H])/C([H])=C([H])/C([H])=C(CC3=CC(N4C)=C(Cl)C(OC)=C3)\C)([H])C)C)([H])CC4=O)=O
EOS-AX0898AR-A014418487021-52-3C12H12N4O4S308.31COC1=CC=C(C=C1)CNC(=O)NC2=NC=C(S2)[N+](=O)[O-]
EOS-AX0899AR-C155858496791-37-8C21H27N5O5S461.53CC1=C(C(=NN1)C)CC2=C(C3=C(S2)N(C(=O)N(C3=O)C)CC(C)C)C(=O)N4CC(CO4)O
EOS-AX0900Armodafinil112111-43-0C15H15NO2S273.35
EOS-AX0901ARRY-520885060-09-3C20H22F2N4O2S420.48
EOS-AX0902ARRY-520 R enantiomer885060-08-2C20H22F2N4O2S420.48CN(C(=O)N1C(SC(=N1)C2=C(C=CC(=C2)F)F)(CCCN)C3=CC=CC=C3)OC
EOS-AX0903AS 602801848344-36-5C25H23N5O2S457.55C1COCCN1CC2=CC=C(C=C2)COC3=NC=CC(=N3)C(C#N)C4=NC5=CC=CC=C5S4
EOS-AX0904ASC-J952328-98-0C23H24O6396.43COC1=C(C=C(C=C1)C=CC(=CC(=O)C=CC2=CC(=C(C=C2)OC)OC)O)OC
EOS-AX0905Ascomycin(FK 520)104987-12-4C43H69NO12792.01CCC1C=C(CC(CC(C2C(CC(C(O2)(C(=O)C(=O)N3CCCCC3C(=O)OC(C(C(CC1=O)O)C)C(=CC4CCC(C(C4)OC)O)C)O)C)OC)OC)C)C
EOS-AX0906Asenapine hydrochloride1412458-61-7C17H17Cl2NO322.23ClC1=C([H])C2=C(C([H])=C1[H])OC3=C([H])C([H])=C([H])C([H])=C3[C@]4([H])[C@]2([H])C([H])([H])N(C([H])([H])[H])C4([H])[H].Cl[H]
EOS-AX0907ASP30261097917-15-1C29H40N8O3S580.74CC(C)S(=O)(=O)C1=CC=CC=C1NC2=NC=NC(=N2)NC3=C(C=C(C=C3)N4CCC(CC4)N5CCN(CC5)C)OC
EOS-AX0908AST 487630124-46-8C26H30F3N7O2529.56CCN1CCN(CC1)CC2=C(C=C(C=C2)NC(=O)NC3=CC=C(C=C3)OC4=NC=NC(=C4)NC)C(F)(F)F
EOS-AX0909Asunaprevir (BMS-650032)630420-16-5C35H46ClN5O9S748.29CC(C)(C)C(C(=O)N1CC(CC1C(=O)NC2(CC2C=C)C(=O)NS(=O)(=O)C3CC3)OC4=NC=C(C5=C4C=C(C=C5)Cl)OC)NC(=O)OC(C)(C)C
EOS-AX0910AT-10190141-22-3C30H30O8518.55CC1=C(C(=C2C(=C1)C(=C(C(=C2C=O)O)O)C(C)C)O)C3=C(C=C4C(=C3O)C(=C(C(=C4C(C)C)O)O)C=O)C
EOS-AX0911AT7519 Hydrochloride902135-91-5C16H18Cl3N5O2418.71C1CNCCC1NC(=O)C2=C(C=NN2)NC(=O)C3=C(C=CC=C3Cl)Cl.Cl
EOS-AX0912AT7519 trifluoroacetate1431697-85-6C18H18Cl2F3N5O4496.27C1CNCCC1NC(=O)C2=C(C=NN2)NC(=O)C3=C(C=CC=C3Cl)Cl.C(=O)(C(F)(F)F)O
EOS-AX0913AT7867 dihydrochloride1431697-86-7C20H22Cl3N3410.77C1CNCCC1(C2=CC=C(C=C2)C3=CNN=C3)C4=CC=C(C=C4)Cl.Cl.Cl
EOS-AX0914Atrasentan173937-91-2C29H38N2O6510.62CCCCN(CCCC)C(=O)CN1CC(C(C1C2=CC=C(C=C2)OC)C(=O)O)C3=CC4=C(C=C3)OCO4
EOS-AX0915Atrasentan hydrochloride195733-43-8C29H39ClN2O6547.08CCCCN(CCCC)C(=O)CN1CC(C(C1C2=CC=C(C=C2)OC)C(=O)O)C3=CC4=C(C=C3)OCO4.Cl
EOS-AX0916Avermectin B171751-41-2C48H72O14873.08CCC(C1C(C)C=CC2(CC3CC(C/C=C(C)/C(OC4CC(OC)C(OC5CC(OC)C(O)C(C)O5)C(C)O4)C(C)/C=C/C=C6COC7C\6(O)C(C(O3)=O)C=C(C)C7O)O2)O1)C
EOS-AX0917Avermectin B1a65195-55-3C48H72O14873.08CCC(C)C1C(C=CC2(O1)CC3CC(O2)CC=C(C(C(C=CC=C4COC5C4(C(C=C(C5O)C)C(=O)O3)O)C)OC6CC(C(C(O6)C)OC7CC(C(C(O7)C)O)OC)OC)C)C
EOS-AX0918Avermectin B1b65195-56-4C47H70O14859.05CC([C@](O1)([H])[C@@](C=C[C@@]21C[C@](O3)([H])C[C@@](O2)([H])C/C([H])=C([C@](O[C@@]4([H])C[C@@](OC)([H])[C@](O[C@@]5([H])C[C@@](OC)([H])[C@](O)([H])[C@](O5)([H])C)([H])[C@](O4)([H])C)([H])[C@@](/C([H])=C([H])/C([H])=C([C@@]67O)\CO[C@]7([H])[C@@](O)([H])C(
EOS-AX0919Avibactam1192500-31-4C7H11N3O6S265.24N=C(O)[C@@]1([H])CC[C@@](N2OS(O)(=O)=O)([H])CN1C2=O
EOS-AX0920AVL-2921202757-89-8C22H22FN5O3423.44COCCOC1=CC=C(C=C1)NC2=NC=C(C(=N2)NC3=CC(=CC=C3)NC(=O)C=C)F
EOS-AX0921AVL-292 benzenesulfonate1360053-81-1C28H28FN5O6S581.62C=C/C(O)=N/C1=CC(/N=C(N2)\C(F)=CN=C2NC3=CC=C(OCCOC)C=C3)=CC=C1.OS(C4=CC=CC=C4)(=O)=O
EOS-AX0922Avosentan290815-26-8C23H21N5O5S479.51CC1=CN=C(C=C1)S(=O)(=O)NC2=C(C(=NC(=N2)C3=CC=NC=C3)OC)OC4=CC=CC=C4OC
EOS-AX0923AXL1717477-47-4C22H22O8414.41COC1=CC(=CC(=C1OC)OC)C2C3C(COC3=O)C(C4=CC5=C(C=C24)OCO5)O
EOS-AX0924AZ201233339-22-4C21H24N4O3S412.51CC1COCCN1C2=NC(=NC(=C2)C3(CC3)S(=O)(=O)C)C4=C5CC=NC5=CC=C4
EOS-AX0925Azaphen24853-80-3C16H21Cl2N5O370.28CN1CCN(C2=NN=C3C(N(C4=CC=CC=C4O3)C)=C2)CC1.Cl.Cl
EOS-AX0926Azaphen dihydrochloride monohydrate63302-99-8C16H23Cl2N5O2388.29CN(CC1)CCN1C2=NN=C3C(N(C)C4=C(O3)C=CC=C4)=C2.O.Cl.Cl
EOS-AX0927Azathramycin76801-85-9C37H70N2O12734.96CC[C@](O1)([H])[C@]([C@@](O)([H])[C@@](NC[C@](C[C@]([C@@](O[C@@]2([H])[C@@](O)([H])[C@](N(C)C)([H])C[C@@](O2)([H])C)([H])[C@@]([C@@](O[C@@]3([H])C[C@]([C@](O)([H])[C@](O3)([H])C)(OC)C)([H])[C@@](C1=O)([H])C)([H])C)(O)C)([H])C)([H])C)(O)C
EOS-AX0928AZD1152722543-31-9C26H31FN7O6P587.54CCN(CCCOC1=CC2=C(C=C1)C(=NC=N2)NC3=NNC(=C3)CC(=O)NC4=CC(=CC=C4)F)CCOP(=O)(O)O
EOS-AX0929AZD76871166827-44-6C21H25N3O3367.44CC1=C(N=C(C(=N1)C)C(=O)N)C2=CC=C(C=C2)C3CCC(CC3)CC(=O)O
EOS-AX0930Balaglitazone199113-98-9C20H17N3O4S395.43CN1C(=NC2=CC=CC=C2C1=O)COC3=CC=C(C=C3)CC4C(=O)NC(=O)S4
EOS-AX0931Balapiravir690270-29-2C21H30N6O8494.5CC(C)C(=O)OCC1(C(C(C(O1)N2C=CC(=NC2=O)N)OC(=O)C(C)C)OC(=O)C(C)C)N=[N+]=[N-]
EOS-AX0932BAM7331244-89-4C21H19N5O2S405.47CCOC1=CC=CC=C1NN=C2C(=NN(C2=O)C3=NC(=CS3)C4=CC=CC=C4)C
EOS-AX0933BAN ORL 24475150-69-7C27H37Cl2N3O2506.51C1CC(N(C1)CC2=CC=CC=C2)C(=O)NCCCN3CCC4(CC3)C5=CC=CC=C5CO4.Cl.Cl
EOS-AX0934Bardoxolone218600-44-3C31H41NO4491.66CC1(CCC2(CCC3(C(C2C1)C(=O)C=C4C3(CCC5C4(C=C(C(=O)C5(C)C)C#N)C)C)C)C(=O)O)C
EOS-AX0935Bardoxolone methyl218600-53-4C32H43NO4505.69CC1(CCC2(CCC3(C(C2C1)C(=O)C=C4C3(CCC5C4(C=C(C(=O)C5(C)C)C#N)C)C)C)C(=O)OC)C
EOS-AX0936Baricitinib phosphate1187595-84-1C16H20N7O6PS469.41CCS(=O)(=O)N1CC(C1)(CC#N)N2C=C(C=N2)C3=C4C=CNC4=NC=N3.OP(=O)(O)O
EOS-AX0937Bavisant929622-08-2C19H27N3O2329.44O=C(C1=CC=C(CN2CCOCC2)C=C1)N(CC3)CCN3C4CC4
EOS-AX0938Bavisant dihydrochloride929622-09-3C19H29Cl2N3O2402.36O=C(C1=CC=C(CN2CCOCC2)C=C1)N(CC3)CCN3C4CC4.Cl.Cl
EOS-AX0939Bavisant dihydrochloride hydrate1103522-80-0C19H31Cl2N3O3420.37C1CC1N2CCN(CC2)C(=O)C3=CC=C(C=C3)CN4CCOCC4.O.Cl.Cl
EOS-AX0940Bay 60-7550439083-90-6C27H32N4O4476.57CC1=C2C(=O)N=C(NN2C(=N1)C(CCCC3=CC=CC=C3)C(C)O)CC4=CC(=C(C=C4)OC)OC
EOS-AX0941BAY 61-3606732983-37-8C20H18N6O3390.4COC1=C(C=C(C=C1)C2=CC3=NC=CN3C(=N2)NC4=C(C=CC=N4)C(=O)N)OC.Cl
EOS-AX0942BAY 61-3606 dihydrochloride648903-57-5C20H20Cl2N6O3463.32COC1=C(C=C(C=C1)C2=CC3=NC=CN3C(=N2)NC4=C(C=CC=N4)C(=O)N)OC.Cl.Cl
EOS-AX0943Bay 65-1942 free base600734-02-9C22H25N3O4395.45O=C(C=CC=C/1OCC2CC2)C1=C(NC3=C4COC(N3)=O)/C=C4C5CCCNC5
EOS-AX0944Bay 65-1942 HCl salt600734-06-3C22H26ClN3O4431.91C1CC(CNC1)C2=CC(=C3C(=O)C=CC=C3OCC4CC4)NC5=C2COC(=O)N5.Cl
EOS-AX0945Bay 65-1942 R form758683-21-5C22H25N3O4395.45C1CC(CNC1)C2=CC(=C3C(=O)C=CC=C3OCC4CC4)NC5=C2COC(=O)N5
EOS-AX0946Bazedoxifene198481-32-2C30H34N2O3470.6CC1=C(N(C2=C1C=C(C=C2)O)CC3=CC=C(C=C3)OCCN4CCCCCC4)C5=CC=C(C=C5)O
EOS-AX0947Bazedoxifene acetate198481-33-3C32H38N2O5530.65CC1=C(N(C2=C1C=C(C=C2)O)CC3=CC=C(C=C3)OCCN4CCCCCC4)C5=CC=C(C=C5)O.CC(=O)O
EOS-AX0948BCX 1470217099-43-9C14H10N2O2S2302.38C1=CSC(=C1)C(=O)OC2=CC3=C(C=C2)C=C(S3)C(=N)N
EOS-AX0949BCX 1470 methanesulfonate217099-44-0C15H14N2O5S3398.48CS(=O)(=O)O.C1=CSC(=C1)C(=O)OC2=CC3=C(C=C2)C=C(S3)C(=N)N
EOS-AX0950Benfotiamine22457-89-2C19H23N4O6PS466.45CC1=NC=C(C(=N1)N)CN(C=O)C(=C(CCOP(=O)(O)O)SC(=O)C2=CC=CC=C2)C
EOS-AX0951Betulinic acid472-15-1C30H48O3456.7CC(=C)C1CCC2(C1C3CCC4C5(CCC(C(C5CCC4(C3(CC2)C)C)(C)C)O)C)C(=O)O
EOS-AX0952BEZ235 Tosylate1028385-32-1C37H31N5O4S641.74CC1=CC=C(C=C1)S(=O)(=O)O.CC(C)(C#N)C1=CC=C(C=C1)N2C3=C4C=C(C=CC4=NC=C3N(C2=O)C)C5=CC6=CC=CC=C6N=C5
EOS-AX0953B-HT 92036085-73-1C10H17Cl2N3S282.23C=CCN1CCC2=C(SC(N)=N2)CC1.Cl.Cl
EOS-AX0954BIBX 1382196612-93-8C18H19ClFN7387.84CN1CCC(NC2=NC=C3C(C(NC4=CC(Cl)=C(F)C=C4)=NC=N3)=N2)CC1
EOS-AX0955Bilobalide33570-04-6C15H18O8326.3O=C1O[C@]([C@]([C@@](C2([H])[H])(C(C([H])([H])[H])(C([H])([H])[H])C([H])([H])[H])O[H])([C@@]3([H])O[H])[C@](C4([H])[H])1[C@@]2([H])OC4=O)([H])OC3=O
EOS-AX0956Bitopertin845614-11-1C21H20F7N3O4S543.46CC(C(F)(F)F)OC1=C(C=C(C=C1)S(=O)(=O)C)C(=O)N2CCN(CC2)C3=C(C=C(C=N3)C(F)(F)F)F
EOS-AX0957Bitopertin (R enantiomer)845614-12-2C21H20F7N3O4S543.46CC(C(F)(F)F)OC1=C(C=C(C=C1)S(=O)(=O)C)C(=O)N2CCN(CC2)C3=C(C=C(C=N3)C(F)(F)F)F
EOS-AX0958Bivalirudin Trifluoroacetate128270-60-0C98H138N24O332180.29CC[C@]([C@@](/N=C(O)/[C@](/N=C(O)/[C@](/N=C(O)/[C@](/N=C(O)/[C@](/N=C(O)/C/N=C(O)/[C@](/N=C(O)/C/N=C(O)/C/N=C(O)/C/N=C(O)/C/N=C(O)/[C@]1([H])CCCN1C([C@](/N=C(O)/[C@]2([H])CCCN2C([C@@](N)([H])CC3=CC=CC=C3)=O)([H])CCCNC(N)=N)=O)([H])CC(O)=N)([H])CC(O)=O)([H
EOS-AX0959BIX02188334949-59-6C25H24N4O2412.19
EOS-AX0960BMN-673 8R,9S1207456-00-5C19H14F2N6O380.35O=C1C2=CC(F)=CC(N[C@H](C3=CC=C(F)C=C3)[C@H]4C5=NC=NN5C)=C2C4=NN1
EOS-AX0961BMS 299897290315-45-6C24H21ClF3NO4S511.94
EOS-AX0962BMS345541 hydrochloride547757-23-3C14H18ClN5291.78CC1=CC2=C(C=C1)N=C(C3=NC=C(N23)C)NCCN.Cl
-

2017年8月1日星期二

RG-7388 idasanutlin 1229705-06-9 assay 99.2% in GMP plant, C-GMP standard, now COA, NMR, HPLC, MS is ok

 RG-7388 idasanutlin 1229705-06-9
 RG-7388 Idasanutlin intermediate N-1 1229705-05-8
 RG-7388 Idasanutlin intermediate N-2 1219089-31-2
 RG-7388 Idasanutlin intermediate N-3 1219086-87-9
 RG-7388 Idasanutlin intermediate N-4 75279-53-7
 RG-7388 Idasanutlin intermediate N-5 85070-48-0

EOS Med Chem produce  RG-7388 idasanutlin 1229705-06-9  assay 99.2% in GMP plant, C-GMP standard, now COA, NMR, HPLC, MS is ok.


 RG-7388 idasanutlin 1229705-06-9 Intermediates, EOS Med Chem have 8;  RG-7388 idasanutlin 1229705-06-9 Impurity we have 10, all from GMP, FDA plant.
Now 1103738-19-7 DMF document is preparing.
Until 2016, Aug, 1103738-19-7 more than produced 2kg API, 10kg Intermediates
-

Filgotinib(GLPG0634) 1206161-97-8

Filgotinib(GLPG0634) 1206161-97-8
intermediate N-1 1206163-59-8
intermediate N-2 1142936-49-9
intermediate N-3 1142943-96-1
intermediate 1010120-55-4
intermediate 1010120-59-8
intermediate 19798-81-3

EOS Med Chem produce Filgotinib(GLPG0634) 1206161-97-8  assay 99.2% in GMP plant, C-GMP standard, now COA, NMR, HPLC, MS is ok.


Filgotinib(GLPG0634) 1206161-97-8 Intermediates, EOS Med Chem have 8; Filgotinib(GLPG0634) 1206161-97-8 Impurity we have 10, all from GMP, FDA plant.
Now 1103738-19-7 DMF document is preparing.
Until 2016, Aug, 1103738-19-7 more than produced 2kg API, 10kg Intermediates

Filgotinib, also known as GLPG0634, is a potent and selective JAK1 inhibitor under investigation for the treatment of rheumatoid arthritis (RA) and Crohn's disease. It is considered a promising agent as it inhibits JAK1 selectively. Filgotinib displayed a selectivity of 30-fold for JAK1- over JAK2-dependent signaling. GLPG0634 dose-dependently inhibited Th1 and Th2 differentiation and to a lesser extent the differentiation of Th17 cells in vitro.

Name: Filgotinib (GLPG0634) 
CAS#: 1206161-97-8 
Chemical Formula: C21H23N5O3S 
Exact Mass: 425.15216 
Molecular Weight: 425.5 
Elemental Analysis: C, 59.28; H, 5.45; N, 16.46; O, 11.28; S, 7.54

Synonym: GLPG0634; GLPG 0634; GLPG-0634. Filgotinib; PubChemSID 163643231
IUPAC/Chemical Name: N-(5-(4-((1,1-dioxidothiomorpholino)methyl)phenyl)-[1,2,4]triazolo[1,5-a]pyridin-2-yl)cyclopropanecarboxamide.
InChi Key: RIJLVEAXPNLDTC-UHFFFAOYSA-N

1: Nakayamada S, Kubo S, Iwata S, Tanaka Y. Recent Progress in JAK Inhibitors for the Treatment of Rheumatoid Arthritis. BioDrugs. 2016 Aug 31. Review. Erratum in: BioDrugs. 2016 Oct 3;:. PubMed PMID: 27577235.
2: Roskoski R Jr. Janus kinase (JAK) inhibitors in the treatment of inflammatory and neoplastic diseases. Pharmacol Res. 2016 Sep;111:784-803. doi: 10.1016/j.phrs.2016.07.038. Epub 2016 Jul 26. Review. PubMed PMID: 27473820.
3: Liu CY, Li Q, Zhou XD. [Inhibition of suppressor of cytokine signaling 1 on lipopolysaccharide-induced mucin5AC hypersecretion and the mechanism in human bronchial epithelial cells]. Zhonghua Yi Xue Za Zhi. 2016 Mar 29;96(12):966-70. doi: 10.3760/cma.j.issn.0376-2491.2016.12.012. Chinese. PubMed PMID: 27045723.
4: Nielsen OH, Seidelin JB, Ainsworth M, Coskun M. Will novel oral formulations change the management of inflammatory bowel disease? Expert Opin Investig Drugs. 2016 Jun;25(6):709-18. doi: 10.1517/13543784.2016.1165204. Epub 2016 Mar 28. PubMed PMID: 26967267.
5: Namour F, Desrivot J, Van der Aa A, Harrison P, Tasset C, van't Klooster G. Clinical Confirmation that the Selective JAK1 Inhibitor Filgotinib (GLPG0634) has a Low Liability for Drug-drug Interactions. Drug Metab Lett. 2016;10(1):38-48. PubMed PMID: 26693854.
6: Namour F. Author's Reply to Srinivas: "Pharmacokinetics and Pharmacokinetic/Pharmacodynamic Modeling of Filgotinib (GLPG0634), a Selective JAK1 Inhibitor, in Support of Phase IIB Dose Selection". Clin Pharmacokinet. 2015 Dec;54(12):1297-8. doi: 10.1007/s40262-015-0336-5. PubMed PMID: 26482170; PubMed Central PMCID: PMC4661215.
7: Srinivas NR. Comment on: "Pharmacokinetics and Pharmacokinetic/Pharmacodynamic Modelling of Filgotinib (GLPG0634), a Selective JAK1 Inhibitor, in Support of Phase IIB Dose Selection". Clin Pharmacokinet. 2015 Dec;54(12):1293-5. doi: 10.1007/s40262-015-0335-6. PubMed PMID: 26482169.
8: Namour F, Diderichsen PM, Cox E, Vayssière B, Van der Aa A, Tasset C, Van't Klooster G. Pharmacokinetics and Pharmacokinetic/Pharmacodynamic Modeling of Filgotinib (GLPG0634), a Selective JAK1 Inhibitor, in Support of Phase IIB Dose Selection. Clin Pharmacokinet. 2015 Aug;54(8):859-74. doi: 10.1007/s40262-015-0240-z. PubMed PMID: 25681059; PubMed Central PMCID: PMC4513223.
9: Menet CJ, Fletcher SR, Van Lommen G, Geney R, Blanc J, Smits K, Jouannigot N, Deprez P, van der Aar EM, Clement-Lacroix P, Lepescheux L, Galien R, Vayssiere B, Nelles L, Christophe T, Brys R, Uhring M, Ciesielski F, Van Rompaey L. Triazolopyridines as selective JAK1 inhibitors: from hit identification to GLPG0634. J Med Chem. 2014 Nov 26;57(22):9323-42. doi: 10.1021/jm501262q. Epub 2014 Nov 17. PubMed PMID: 25369270.
10: Norman P. Selective JAK inhibitors in development for rheumatoid arthritis. Expert Opin Investig Drugs. 2014 Aug;23(8):1067-77. doi: 10.1517/13543784.2014.918604. Epub 2014 May 12. Review. PubMed PMID: 24818516.
-

TERT-BUTYL (3S,4R)-3-AMINO-4-FLUOROPIPERIDINE-1-CARBOXYLATE (CAS NO.1290191-73-9)

China biggest supplier of TERT-BUTYL (3S,4R)-3-AMINO-4-FLUOROPIPERIDINE-1-CARBOXYLATE (CAS NO.1290191-73-9).

Assay HPLC 99.2%, NMR, HPLC, LCMS, MOA, MSDS, COA is ok.
www.eosmedchem.com


-
订阅： 博文 (Atom)